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Detoxification and homeostatic acquisition of metal ions are vital for all living 
organisms. Non-physiological heavy metals are toxic at low concentrations and represent 
major environmental hazards to human health. In particular, cadmium is a toxic 
environmental pollutant linked to a number of ailments including cancer, kidney and 
bone disease and reproductive disorders. The biological effects of cadmium toxicity 
which lead to human disease and the cellular mechanisms for cadmium defense are ill 
defined. Thus, the study of heavy metal detoxification systems represents an important 
research avenue to help combat cadmium related disorders. 
The goal of this research project was to identify novel factors involved in metal 
ion defense in the model eukaryote, Saccharomyces cerevisiae.  A genetic screen led to 
the discovery of Pca1, a P-type ATPase which functions as a cadmium-specific efflux 
pump. Unexpectedly, the PCA1 allele in common laboratory yeast strains possesses an 
inactivating mis-sense mutation which has complicated previous attempts to characterize 
its function.  
A unique feature of Pca1 is a cysteine-rich cytosolic amino terminal extension 
that can participate in metal coordination and regulate expression levels. Under normal 
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conditions, Pca1 is an unstable protein that is ubiquitinated and rapidly degraded by the 
proteasome. However, in the presence of cadmium, ubiquitination is inhibited resulting in 
rapid up-regulation and trafficking of Pca1 to the cell surface for cadmium efflux. An 
autonomous degradation signal within the cysteine-rich domain is necessary and 
sufficient for metal responsive regulation. 
Finally, a second genetic screen was devised to uncover factors involved in Pca1 
degradation. Unexpectedly, components of the ER-associated degradation (ERAD) 
pathway were found to be required for Pca1 turnover in the absence of cadmium. 
Conformational changes associated with cadmium binding to the metal sensing 
degradation signal lead to the escape of Pca1 from ERAD.  
In summary, our data have revealed a novel metal detoxification system in a 
eukaryotic organism mediated by a P-type ATPase that is unique in structure and 
substrate specificity. Furthermore, we have described an unprecedented mode of ligand 
regulated degradation of a cell surface transporter at the ER and have provided the 
mechanistic basis of this regulation.   
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1.1. Cadmium, a Toxic Heavy Metal  
1.1.1. Physical Properties. Cadmium is a non-physiological heavy metal that is 
one of the most serious environmental pollutants. The only known example of a 
biological function for cadmium has been described for the marine diatom Thalassiosira 
weissflogii in which cadmium can replace the zinc cofactor in carbonic anhydrase II 
when cells are growing under extreme zinc deficiency (1). Zinc and cadmium belong to 
the same column on the periodic table (2B) with filled 3d and 4d orbitals and 
consequently they share many physical properties. Cadmium (II) is the only accessible 
reduction state following the loss of two 5s electrons under physiological conditions. 
Thus cadmium is not a redox active metal and does not initiate Fenton reactions directly. 
Cadmium is classified as a soft Lewis acid and has a very high affinity for easily oxidized 
ligands, such as oxygen and sulfur. Cadmium is then expected to displace zinc from 
protein ligands containing a sulfur dominated coordination sphere. Cadmium occurrence 
is mainly associated with other heavy metals including zinc, and to a lesser extent copper 
and lead thus cadmium is an inescapable by-product of metallurgy. The chemical 
properties of cadmium have been implemented into a wide range of technical applications 
that include nickel-cadmium batteries, pigments, and various metal alloys just to name a 
few.  
1.1.2. Human Exposure to Cadmium. It is estimated that up to 30,000 tons of 
cadmium are released into the environment each year where one-half is liberated by 
weathering rocks and the other half is produced by industrial activities (2). The 
manufacturing and disposal of cadmium-containing compounds has led to a significant 
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increase of cadmium exposure to humans. Approximately 512,000 employees in the 
United States work in environments which potentially expose them to cadmium (2). Air 
pollution can also arise from non-human processes such as wind blown cadmium powder 
suspensions at the surface of the earth or dispersion of volcanic gases. Cadmium released 
into the environment ultimately enters the food chain and water supply. Agricultural 
activities contribute to the incorporation of cadmium from soil and minerals into crops 
which are used for human consumption. The cadmium content in soil determines metal 
accumulation in plants which is influenced by natural geological features or industrial 
pollution. Cadmium concentrations in plants typically range from 0.5 - 5µM but can 
reach more than 100µM in hyper-metal-accumulating plants (3). Use of fertilizers greatly 
increases soil cadmium concentrations and acidification enhances solubility and uptake 
into plants (3). The greatest risk for cadmium exposure occurs through cigarette smoke. 
One cigarette contains about 1-2µg of cadmium of which 10% is inhaled into the lungs 
while smoking. While only a small percentage of cadmium is absorbed in the digestive 
tract, up to 50% of inhaled cadmium enters the blood stream (4). Under conditions of iron 
deficiency such as in a low iron diet and pregnancy, cadmium uptake is increased due to 
up-regulation of iron transporters which exhibit broad substrate specificity (4).  
1.1.3. Toxic Cellular Effects and Pathologies of Cadmium Exposure. The 
toxic effects of cadmium on cellular functions are multifarious. The deleterious effects of 
cadmium are believed to stem from its ability to replace essential metal cofactors in 
metalloenzymes and binding to thiol-containing proteins involved in oxidative stress 
defense (e.g., glutathione, thioredoxin and thioredoxin reductase). Consequences include 
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changes in gene expression, cell cycle progression, proliferation, differentiation, signal 
transduction, inhibition of DNA replication and repair, induced apoptosis, endocrine 
disruption and alterations of metal and redox homeostasis (5).  
 The human clinical symptoms of cadmium poisoning are correlated to the organ 
distribution of the metal. Emphysema and chronic rhinitis have been linked to cadmium 
inhalation. Cadmium is classified as a class I pulmonary carcinogen because of the high 
incidence of lung cancer of individuals who were occupationally exposed to cadmium 
(4). Cadmium is likely responsible for the onset of other cancers but the scarcity of data 
has not extended the range of carcinogenicity beyond lung carcinoma. One of the main 
target organs of cadmium toxicity is the kidney. Renal tubular damage is an adverse 
effect resulting from chronic cadmium exposure (4,6,7). Renal damage results in 
inadequate activation of vitamin D which leads to decreased calcium absorption and 
impaired bone mineralization.  Bone disease associated with prolonged cadmium 
exposure was first reported in a cadmium contaminated river basin in Japan where 
several cases of Itai-Itai disease were recognized (4).  
 Cadmium has also been associated with reproductive and developmental defects. 
Cadmium exposure during pregnancy is correlated with an increased incidence of low 
birth weight and spontaneous abortion (4). Cadmium affects steroid synthesis pathways 
and secretion of progesterone, a hormone that plays a critical role in maintaining 
pregnancy (8). In mammals the estrogenic effects of cadmium induce uterine hyperplasia, 
mammary gland development, early onset of puberty, male infertility and breast cancer 
(9,10). Alarmingly, the doses of cadmium which exhibited estrogenic effects were similar 
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to human dietary exposure. Moreover, cadmium could exhibit synergistic estrogenic 
effects in combination with dietary phytoestrogens (9). 
1.1.4. Cadmium Absorption. Cadmium is a non-essential metal and is unlikely 
to enter cells through a transport mechanism specific for cadmium. Cadmium particles 
breathed in through the nose move through the primary olfactory neurons to their final 
destination in the olfactory bulb. In the lungs, cadmium can pass through alveolar cells 
directly into the bloodstream despite an efficient barrier in the lung epithelium for other 
toxic molecules and heavy metals (11). The mechanism by which cadmium reaches 
circulation is not well characterized but likely involves uptake through channels or 
transporters dedicated for essential ions or other biomolecules (Figure 1.1). Ingested 
cadmium enters the digestive tract where the acidic environment favors absorption at the 
apical membrane of enterocytes. The proton-metal Iron(II) cotransporter, DMT1 (DCT1, 
Nramp2), appears to be involved in this process (11). Zinc transporters have also been 
implicated in cadmium uptake. The putative mouse zinc transporter ZIP8 has been 
attributed with cadmium uptake in vascular epithelial cells of testis (12). Moreover, 
deletion or overexpression of Zrt1, a plasma membrane zinc transporter in yeast 
Saccharomyces cerevisiae, affects cadmium uptake (13).  There is also evidence that 
cadmium may permeate cells through calcium channels (14-16).  Cadmium uptake may 
also occur by other mechanisms which may include endocytosis of Cadmium-bound 
molecules, organic cation transporters (OCT) or transporters of other metal ions such as 
manganese  (17) .   
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1.1.5. Subcellular Distribution and Sequestration. Once inside the cell, 
cadmium is sequestered by metallothionine (MT), a cysteine-rich peptide, as well as 
glutathione (GSH) (Figure 1.1).  In eukaryotes this is thought to be the first line of 
defense for neutralizing cadmium and other toxic heavy metals (18-22). In S. cerevisiae, 
GSH-conjugated cadmium is compartmentalized into the vacuole by the ATP-binding 
cassette (ABC) transporter, Ycf1 (23). In plants and fission yeast Schizosaccharomyces 
pombe, cadmium is sequestered by phytochelatin, a GSH polymer (20). It is possible that 
other unidentified cadmium-binding proteins or molecules may exist as has been 
demonstrated for other heavy metals. For example, cytosolic metallochaperones deliver 
copper, a vital yet toxic trace element, as a cofactor to copper-requiring proteins through 
direct protein-protein interactions. This strategy ensures that there is virtually no unbound 
copper in the cytoplasm where it can catalyze unwanted Fenton and Haber-Wiess 
reactions (24). Recently, an iron-binding protein was discovered that ferries iron to its 
storage protein, ferritin (25).  In E. coli, arsenic, a toxic non-physiological metalloid, is 
delivered to an efflux pump by a cytoplasmic protein (26). Thus, intracellular trafficking 
of cadmium may be a carrier mediated process. 
1.1.6. Cadmium Extrusion. In prokaryotes, a plethora of metal efflux pumps, 
including P-type ATPases, ATP binding cassette (ABC) transporters, resistance-
nodulation-cell division transporters (RND) and cation diffusion facilitators (CDF), have 
all been described (27-29). In Gram-Positive bacteria cadmium extrusion is mediated 
through the P1B-type ATPase, CadA (30). Aside from known bacterial metal efflux 
systems, the mechanisms of cadmium efflux in eukaryotes remain largely unknown. 
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Recently, the yeast ABC transporter, Yor1, has been proposed to efflux GSH-conjugated 
cadmium out of the cell (31). In plants, several P-type ATPases which resemble the 
bacterial divalent (zinc(II)/cobalt(II)/cadmium(II)/lead(II)) cation transporters and an 
ABC transporter have been implicated in cellular cadmium efflux (32-34).  In humans, 
the excretion rate of cadmium is relatively low (35). The long residence time in the body 
likely reflects the high affinity of cadmium for sulfhydryl groups of cellular ligands and 
the lack of an efficient excretion system. Mammalian studies have suggested that 
multidrug resistance proteins (MRP’s) could transport GSH or cysteine conjugated 
cadmium out of hepatocytes and renal epithelial cells (36,37). Further characterization of 
cadmium extrusion systems will ultimately enhance our ability to combat cadmium 
related disorders. 
1.1.7. Protective Cellular Responses to Cadmium. Cells regulate a number of 
biochemical pathways to protect themselves from cadmium toxicity. In mammals, both 
GSH and MT gene transcription are induced by the MTF-1 transcription factor in 
response to cadmium and oxidative stress (22,38). In S. cerevisiae, copper sensing by the 
Ace1 transcription factor induces MT production (39), however cadmium induction of 
MT is strain specific and the transcription factor responsible is unknown (40).  Cadmium 
up-regulates GSH and other antioxidant enzymes (superoxide dismutase, thioredoxin and 
thioredoxin reductase) by thiol dependent activation of the Yap1 stress response regulator 
(41). Remarkably, sulfur metabolism in both yeast and mammals can be reorganized in 
response to cadmium resulting in a significant increase in GSH production. This 
restructuring of transcriptional circuitry is accomplished by cadmium induced 
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inactivation of S. cerevisiae Met4 and mammalian Nrf2 or the ubiquitination and 
proteasomal degradation of S. pombe, Zip1 transcription factor (42). Cadmium also 
modifies expression levels of other stress responsive proteins such as heat shock proteins 
(HSPs). HSPs play an important role in protein folding and in the degradation of 
damaged or mis-folded proteins. Induction of HSPs is most likely a response to 
cadmium-mediated denaturation and/or oxidative damage of proteins.  Cells can also 
protect themselves by curbing cadmium uptake. In S. cerevisiae, zinc, cobalt or cadmium 
can trigger the degradation of the ZRT1 zinc transporter preventing excessive metal 
uptake (43). The evolution of these diverse cellular responses underscores the 
significance of cellular defense against cadmium toxicity.  
 
Figure 1.1. A model of Cd metabolism in yeast S. cerevisiae and mammals. 
Divalent nutritional metal transporters mediate Cd uptake across the plasma 
membrane. Intracellular glutathione (GSH) and metallothionine (MT) play critical 
roles in Cd chelation. In yeast, Ycf1 sequesters GSH-conjugated Cd into the 
vacuole. Cd induces detoxification pathways through several mechanisms, including 
enhanced gene expression by Yap1, Ace1, Met4 in yeast and MTF1 and Mrf2 in 
mammals. Cadmium extrusion factors are largely unknown. 
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1.2. P1B-Type ATPases 
1.2.1. Function and Classification. P-type ATPases are an important family of 
active membrane transporters that play fundamental roles in cell function by maintaining 
ion gradients.  They are ubiquitous and are involved in transport processes in virtually all 
living organisms. P-type pumps are required for nutrient uptake, muscle contraction, 
neurotransmission, signaling and excretion of toxic heavy metals (29,32,33,44-48). P-
type ATPases are categorized into 5 main groups (Types I-V) based on sequence 
homology. Within these branches several subtypes or classes can be distinguished based 
on substrate specificity. For instance, the P1B class transports “soft” transition metals 
copper(I), silver(I) copper(II), zinc(II), lead(II), mercury(II), cobalt(II) and cadmium(II)). 
P1B ATPases are found in almost all organisms ranging from bacteria to humans. Based 
on substrate specificities, they are further divided into monovalent and divalent 
translocating ATPases (49).  P1B ATPases are vital for metal detoxification in bacteria 
(29). In eukaryotes copper translocating ATPases are linked to two human genetic 
diseases, Wilson and Menkes disease. Consequently, because of their medical relevance, 
these copper pumps have received much attention regarding their mechanism of action 
and regulation. Cloning of the genes that are defective in Wilson and Menkes disease 
revealed that two P1B-type ATPases, ATP7a (MNK) and ATP7b (WND) are essential for 
copper acquisition and excretion in humans. Yeast S. cerevisiae also possesses a 
homologue of WND and MNK (50). The pathogenic yeast, C. albicans, expresses an 
additional copper efflux ATPase (CaCRP) at the plasma membrane which leads to high 
copper tolerance (51). Plants contain several P1B-type ATPases (eight in A. thaliana) that 
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appear to be involved in subcelluar distribution and tissue compartmentalization of metal 
ions (32,33).  
1.2.2. Structure and Mechanism of Action. Crystal structures have been solved 
for Type III ATPases (Ca2+-ATPase and Na+,K+-ATPase) and a Type II ATPase (H+-
ATPase). However, little is known about the structure and mechanism of action of metal 
transporting PIB-type ATPases which are structurally distinct from Type II and III P-type 
ATPases. P1B ATPases are composed of three principle domains, an ATP-binding domain 
(N domain), a phosphorylation domain (P domain), and an actuator domain (A domain) 
(44) (Figure 1.2.). Unlike other P-type ATPase family members, P1B-type ATPases 
possess 8 transmembrane domains, a CPX or SPC motif at the 6th transmembrane helix, 
and metal binding domains (MBDs) at the N and/or C terminus. Structures of these 
domains have been solved separately. However, a complete structure of a full length  
P1B-type ATPase is yet to be solved. 
 
 
 
 
Figure 1.2. Schematic depiction of P1B-type ATPase Conserved Features. Eight 
transmembrane helixes, metal binding domains (M) containing GMXCXXC motif, 
CPX motif within 6th transmembrane helix, an actuator domain (A), a 
phosphorylation domain (P), and a nucleotide binding domain (N) are indicated.  
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The postulated mechanism of ion translocation of P1B-type ATPases is based on 
the Post-Albers cycle for the Na+/K+ ATPase (45) (Figure 1.3.). Cytosolic ATP and metal 
ions bind to the E2 state, which converts the enzyme to the E1 form.  Conformational 
changes resulting from ATP phosphorylation and dephosphorylation drive metal ion 
translocation across the membrane. After releasing Pi, the enzyme is converted to the E2 
form to initiate the next cycle. It is not known yet how many metal ions are translocated 
per cycle and whether there is counter translocation of ion(s) from the other side of the 
membrane 
 
 
 
 
 
 
 
Figure 1.3. P1B-Type ATPase catalytic cycle. E1, E2, E1P and E2P represent the 
conformations based on the Post-Albers model for the Na+-K+ ATPase. Mn+ 
represents a metal transported by the enzymes. “n” indicates the uncertainty on the 
specific stoichiometry of transport. Mn+cyt and Mn+out represent the cytoplasmic or 
extracellular/luminal localization of the transported metals. Figure adapted from 
(49) 
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The CPX/SPC motif at the 6th transmembrane helix is thought to coordinate metal 
ions during translocation. Sequence alignments and site-directed mutagenesis have 
predicted other potential metal binding residues located in the 7th and 8th trans-membrane 
domains as well (49,52). However, metal coordination during transport and the 
mechanisms of P1B-type ATPases remain to be determined. Moreover, the molecular 
determinant(s) that define substrate specificity are not known. 
Most P1B-type ATPases possess N and/or C-terminal MBDs that are believed to 
play roles in catalysis and/or regulation (52). The human Cu+ transporting ATPases, 
WND and MNK, possess 6 MBDs (~70 amino acids, βαββαβ fold) at the N-terminus 
(53,54). This domain is conserved in many P1B-type ATPases, and the number of repeats 
can vary. Several atypical MBDs have also been identified (55,56).  The conserved MBD 
contains a GMXCXXC motif in which two cysteine residues coordinate a single Cu+ ion 
(53,54) . The Atx1 metallochaperone delivers copper(I) to these domains through direct 
docking to the 2nd and 4th domains of WND, suggesting distinct functions of these 
domains (57,58). Despite structural and metal binding properties have been well 
characterized, their roles in ATPase function are not clear yet. Copper binding was 
initially proposed as a substrate recognition step followed by transfer of copper(I) to the 
translocation pore. Consistently, several disease causing mutations within WND have 
been mapped to Atx1 binding sites (59,60). However, site-directed mutagenesis and 
deletion of MBDs also suggest a regulatory role for these domains in the catalytic 
activities of P1B-type ATPases.  Recently, it was proposed that the metallochaperone can 
transfer a metal substrate directly to the trans-membrane metal-binding site for 
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translocation (61). Collectively, while significant progress has been made in the metal 
binding properties of MBDs, their functional roles in activity and/or regulation of P1B-
type ATPases remain elusive.  
1.2.3. Regulation. Several modes of regulation control expression levels, 
subcelluar localization, and activities of P1B-type ATPases. Transcriptional control in 
response to metal ions appears to be a major regulatory mechanism in bacteria and plants 
(29,32,33,45).  However, in mammals metal mediated regulation of Copper(I)-
transporting P1B-type ATPases mainly relies on alterations of their subcelluar trafficking 
(59,62-65).  In a low copper medium, the human MNK and WND proteins are localized 
to the trans-Golgi network where they transport copper for incorporation into secretory 
proteins. When copper levels are elevated, MNK is mobilized to the plasma membrane in 
a reversible manner. The biological significance of this trafficking event is that MNK 
participates in copper extrusion to protect cells from toxicity. In the liver, excess copper 
mobilizes WND from the trans-Golgi network to a cytoplasmic vesicle-like compartment 
associated with the canicular membrane of bile ducts. The biological significance appears 
to be an important mechanism for excretion of excess copper into bile to maintain 
systemic copper homeostasis. However, it is not known exactly what molecular changes 
(e.g. conformational change, phosphorylation, disulfide bond formation, and/or 
interaction with other proteins) trigger trafficking of MNK and WND in response to 
copper.    
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1.3. Subcellular Trafficking of Membrane Proteins in Yeast  
 Membrane proteins including P1B-type ATPases traffic through the secretory 
pathway to their final destination. In S. cerevisiae, as many as 282 membrane solute 
transporters have been identified of which a minimum of 125 reside at the cell surface 
(66). A number of these transporters have been reported to be subject to strict regulation 
in context of their trafficking and degradation according to environmental conditions. 
Many of the same principles which govern the regulation of transporters appear to be 
conserved in plants and animals making yeast a powerful system for dissecting these 
mechanisms in detail.   
  1.3.1. Folding, Maturation and Assembly at the Endoplasmic Reticulum. 
The endoplasmic reticulum (ER) is the gateway for entry into the secretory pathway. 
Newly synthesized membrane proteins are cotranslationally integrated into the ER 
through a narrow cytosolic channel formed by the heterotrimeric Sec61p complex. Most 
transmembrane proteins do not possess a cleavable signal sequence but instead are 
targeted to the ER by the first hydrophobic segment which functions as an internal signal 
sequence (67). Translocation is halted by hydrophobic stop-transfer segments within the 
primary amino acid sequence where charged residues flanking the hydrophobic segment 
are believed to determine the orientation of the segment across the membrane (68). 
During or after translocation protein folding is assisted by various chaperones. In some 
instances proteins acquire N-linked glycosylation, disulfide bond formation or must 
oligomerize into higher order structures before being deemed fully mature (69). Correct 
protein folding and assembly is often inefficient and can be hindered by genetic error and 
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cellular stress. The accumulation of unfolded proteins induces the unfolded protein 
response (UPR) pathway which alleviates ER stress by inhibiting protein translation and 
up-regulating protein folding and degradation pathways (70) .  
1.3.2. ER to Golgi Trafficking. After passing all quality control checkpoints, 
proteins are packaged into transport vesicles destined for the Golgi prior to sorting into 
the secretory pathway.  Intracellular sorting between compartments requires vesicle 
carriers that are released from a donor to an acceptor compartment following vesicle 
fusion (71). Correctly folded and assembled cargo proteins are packaged into COPII-
coated vesicles and are transferred to the Golgi network. For some cargo proteins, 
packaging requires a diacidic motif which is recognized by the COPII protein, Sec24 
(72). Cargo receptors and components of the membrane fusion machinery are returned to 
the ER by COPI coated vesicles (Figure 1.4.).  
1.3.3. Golgi to Plasma Membrane Trafficking. The mechanism of cell surface 
targeting of plasma membrane proteins is largely unknown. Once at the Golgi apparatus 
membrane proteins are sorted to the plasma membrane or other secretory compartments 
via secretory vesicles (SV). At least two different routes, involving vesicle populations of 
different densities, low-density secretory vesicles (LDSV) or high density secretory 
vesicles (HDSV) carry distinct exocytic cargo en route to the plasma membrane (73).  
Association with membrane lipid rafts is required for proper trafficking of some 
membrane proteins to the plasma membrane (74). 
  1.3.4. Ubiquitin Dependent Endocytosis and Vacuolar Degradation. Proteins 
are often marked for degradation by post-translational conjugation to ubiquitin, a 76 
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amino acid protein that is conserved from yeast to humans (75). The first step in 
ubiquitination is the activation of the C-terminal α carboxyl group of ubiquitin by ATP 
resulting in an adenyl intermediate followed by the subsequent formation of a thiol ester 
bond with a cysteine of an (E1) ubiquitin-activating enzyme. Ubiquitin is then transferred 
to a cysteine of a ubiquitin-conjugating enzyme (E2). Ubiquitin loaded E2s bind 
specifically to ubiquitin ligases (E3) that bind directly to protein substrates. The E3s 
themselves can be conjugated with ubiquitin through a thioester bond before substrate 
attachment, or act as a bridge between the activated E2 and its substrate. Ubiquitin is 
usually attached through an isopeptide bond to the ε-amino group of a lysine residue of 
the substrate. 
Several cell surface transporters are down-regulated by ubiquitin-dependent 
endocytosis followed by vacuolar targeting via endosomal compartments. A key factor in 
this process is the ubiquitin E3 ligase Rsp5 along with other adaptor proteins which can 
mediate client specific ubiquitination of substrates (76).  
 The ubiquitin moiety acts as an internalization signal which is recognized by 
ubiquitin binding proteins that contain variable effector domains which recruit clathrin 
proteins that function in membrane bending and invagination. Internalization is also 
thought to require correct organization of the actin cytoskeleton as several transporters 
accumulate as ubiquitin conjugates in mutants impaired in cytoskeleton formation (77). 
Following vesicle budding and internalization, ubiquitinated cargos are transported into 
endocytic compartments called early endosomes (EE). At this holding station, endocytic 
vesicles can be recycled back to the plasma membrane or can fuse with the limiting  
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Figure 1.4. Trafficking of membrane proteins in yeast.  Correctly folded and 
assembled cargo proteins are packaged into COPII-coated vesicles and are 
transported to the Golgi network. Terminally misfolded proteins (*) are 
retranslocated to the cytosol for proteasome dependent degradation. COPI proteins 
induce formation of return vesicles that retrieve cargo receptors and components of 
membrane fusion machinery to the ER. Cell surface proteins are transported from 
the trans-Golgi network to the plasma membrane (PM) via secretory vesicles (SV). 
Ubiquitin dependent endocytosis targets some plasma membrane proteins to the 
early endosome (EE). Internalized substrates can be recycled back to the plasma 
membrane or can proceed to late endosomes/multivesiclar body (LE/MVB) where 
ubiquitinated cargo is internalized into vesicles. Fusion of the mature LE/MVB with 
the vacuole delivers internalized contents for vacuolar degradation. Under certain 
conditions some plasma membrane proteins are directly sorted to the vacuole for 
degradation. 
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membrane of the late endosome/multivesiclar body (LE/MVB). At the limiting 
membrane of the LE/MVB ubiquitinated substrates are internalized into vesicles. 
Subsequent fusion with the vacuole delivers the internal vesicles carrying ubiquitinated 
cargos into the vacuolar lumen for degradation by vacuolar proteases and lipases. This 
process allows for discrimination in the sorting of proteins to the vacuole limiting 
membrane or to the lumen of this organelle for degradation. In some instances, newly 
synthesized membrane proteins are ubiquitinated at the Golgi where they are diverted 
directly to the vacuole for degradation without ever reaching the plasma membrane 
(Figure 1.4.).  
  1.3.5. Physiological Regulation of Transporter Trafficking. Organisms must 
meet the demands of changing conditions within the environment. Several nutritional 
transporters are down-regulated by targeting to the vacuolar degradation pathway in 
response to specific stimuli. The general amino acid permease, Gap1, is active under 
conditions of limiting nitrogen supply. Under these conditions the GAP1 gene is 
transcribed and newly synthesized protein is targeted directly to the plasma membrane. 
When a preferred nitrogen source is available, such as ammonia, the GAP1 gene is 
repressed and pre-synthesized Gap1 is rapidly removed from the plasma membrane 
through ubiquitin dependent endocytosis and is sorted into the MVB/vacuolar pathway 
for degradation (78). When cells are grown with glutamate as the sole nitrogen source, 
newly synthesized Gap1 is ubiquitinated by Rsp5 and is directly targeted to the 
MVB/vacuolar pathway without ever reaching the plasma membrane (79).  
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Metal transporters are also tightly regulated due to the requirement of nutritional 
metals at specific concentrations which is critical to avoid potential toxicity.  Zrt1, a high-
affinity Zn transporter, is rapidly internalized by Rsp5-dependent ubiquitination within 
minutes of exposure to high Zn levels to prevent toxicity (43). The Mn transporters, Smf1 
and Smf2, are targeted to the vacuole by Rsp5 dependent ubiquitination in response to 
excess Mn (80). Interestingly, mutations that abolish Smf1 transport activity affect 
trafficking which suggests that conformational states during metal transport are 
recognized by the ubiquitination machinery (81).  
There is growing evidence that direct substrate binding to transporters plays a 
pivotal role in controlling membrane trafficking. The nucleotide transporter Fur4 
undergoes Rsp5 dependent ubiquitination and internalization in the presence of excess 
uracil. If synthesized in the presence of its uracil substrate, Fur4 undergoes Rps5 
mediated ubiquitination at the Golgi and is directly sorted to the vacuolar degradation 
pathway (82,83). A Fur4 mutant, which has a very low affinity for uracil, circumvents 
vacuolar sorting and instead localizes to the plasma membrane despite the presence of 
intracellular uracil. This observation suggests that binding of uracil to Fur4 leads to 
conformational changes that facilitate ubiquitination. 
Perhaps the best illustration of trafficking regulation by substrate binding is that 
of the Arn1 ferrichrome (FC) transporters. S. cerevisiae can uptake iron bound to 
siderophores by two separate systems, one of which requires the ARN family of iron-
siderophore transporters. In the absence of its FC substrate Arn1 localizes to endosome-
like intracellular vesicles. It has been proposed that low concentrations of endocytosed 
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FC substrate a sensed by a high affinity binding site of the Arn1 transporter which 
promotes sorting from endosomes to the cell surface for iron-siderophore uptake. While 
at the cell surface, excess amounts of FC bind to a low affinity binding site of Arn1, 
which induces internalization and targeting to the MVB/vacuolar pathway for 
degradation thus preventing excess FC uptake (84,85).  
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1.4. Quality Control and Regulated Degradation at the ER.  Misfolded proteins which 
do not pass ER quality control specifications are transported back across the ER 
membrane into the cytosol where they are almost always ubiquitinated before 
degradation by the 26S proteasome (86-89). This process has been referred to as ER-
associated degradation (ERAD) (90). Inefficiencies in ERAD result in accumulation of 
malfolded proteins and cell death leading to various diseases such as diabetes, 
inflammation and neurological disorders including Alzheimer’s disease, Parkinson’s 
disease and bipolar disorders (91)  
 1.4.1. Recognition of soluble luminal substrates 
Hsp70 chaperones, including mammalian BiP or yeast Kar2, bind exposed residues with 
overall hydrophobic character which would be normally buried in a properly folded 
protein (68). Hsp70 chaperones bind and release substrates in an ATP dependent manner. 
Hsp70s like BiP and its co-chaperones are essential for maintaining solubility of newly 
translocated proteins which in turn facilitates proper folding (92). It is then logical that 
luminal chaperones are also important for delivery and/or targeting of terminally mis-
folded proteins for ERAD (93). Indeed Kar2 is required for efficient degradation of 
several soluble luminal ERAD substrates in yeast (94). 
 Instead of binding avidly to hydrophobic peptides, some ER luminal chaperones 
known as lectins preferentially interact with distinct sugar residues which are appended to 
secretory proteins by ER resident oligosaccharyltransferases (95-97). A core Glc3-Man9-
GlcNAc2 glycan (where Glc is glucose, Man is mannose and GlcNac is N-
acetylglucosamine) is added to asparagine residues. The trimming and re-addition of 
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glucose residues act as a folding “timer”. The monoglucosylated species has a high 
affinity for calnexin and calreticulin, which are integral membrane and soluble lectins 
located in the ER, respectively. Both calnexin and calreticulin interact with ERp57, a 
member of the PDI family which forms transient disulfide bonds with calnexin and 
calreticulin-bound proteins to assist in folding (98,99). This “timer” is controlled by 
mannosidase I, which slowly cleaves the α1,2-linked mannose residue from the middle 
branch generating a Man8GlcNAc2 glycan which leads to association with ER 
degradation-enhancing 1,2-mannosidase-like protein (EDEM)  or Htm1p/Mnl1p in yeast 
(100-102). EDEM then diverts misfolded proteins for dislocation into the cytosol and 
proteasomal degradation. 
1.4.2. Recognition of Integral Membrane ERAD Substrates. Little is known 
about how misfolded integral membrane proteins are recognized and sorted into the 
ERAD pathway but like luminal substrates this process likely involves the exposure of 
hydrophobic residues which are normally buried in a native state. Since the ER 
membrane forms a barrier between the ER lumen and the cytosol, misfolded lesions 
present in luminal domains or cytosolic domains of integral membrane proteins are 
spatially separated and require different recognition factors. Integral membrane substrates 
can be classified according to where misfolding occurs within the protein. Integral 
membrane proteins with lesions that occur within cytoplasmic domains utilize the 
ERAD-C pathway, whereas misfolding that occurs in luminal or transmembrane domains 
follow the ERAD-L and ERAD-M pathways, respectively (Figure 1.5.).  
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Cytosolic Hsp70 chaperones and Hsp40 co-chaperones have been proposed to 
play roles in the recognition of ERAD-C substrates by binding exposed hydrophobic 
residues (93). However it is uncertain whether cytoplasmic chaperones maintain protein 
solubility by preventing aggregation of exposed hydrophobic residues or whether they 
play an active role in substrate recognition and recruitment to the ERAD machinery. ER 
resident E3 ubiquitin ligases may also play a role in recognition of ERAD-C substrates.   
Integral membrane proteins with luminal lesions utilize many of the same factors 
involved in the recognition of misfolded soluble proteins that reside in the ER lumen. 
These include luminal Hsp70/40 chaperones (Kar2/Jem1 and Scj1), protein disulfide 
isomerase (PDI), and putative carbohydrate binding lectins (Yos9 and Htm1/Mnl1) (93). 
Factors involved in the recognition of lesions within the transmembrane domain (ERAD-
M) are largely unknown. It has been proposed that they can be directly recognized by 
ER-membrane localized E3 ligases.  
1.4.3. Retranslocation. Proteasomal degradation requires retrograde transport out 
of the ER to the cytosol. It remains unknown how exactly this occurs. It has been 
postulated that retranslocation occurs through Sec61, which is the major component of 
the translocation channel that imports polypeptides into the ER (103,104). Nevertheless, 
Sec61 cannot be the only retranslocation channel as integral membrane ERAD substrates 
are degraded proficiently in sec61 mutants.  
In most cases ubiquitination plays an integral part in the retranslocation process 
and has been proposed to serve as a molecular ratchet by preventing the polypeptide from 
slipping back through the retranslocation channel. Since the catalytic domains of ER 
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resident E3 ubiquitin ligases are located in the cytoplasm, luminal ERAD substrates must 
be retranslocated to the cytosolic face of the ER prior to ubiquitination. However, for 
integral membrane ERAD substrates containing cytosolic domains it is uncertain if 
retranslocation precedes ubiquitination. 
1.4.4. Ubiquitination of ERAD Substrates. Nearly all ERAD substrates are 
polyubiquitinated prior to degradation by the proteasome (88). In S. cerevisiae, the 
ubiquitination of ERAD substrates is mediated by two ER resident RING member 
ubiquitin E3 ligases, Hrd1 and Doa10   (105) (106). The catalytic RING domains of both 
Hrd1 and Doa10 are located on the cytoplasmic face of the ER. Doa10 also resides within 
the nuclear envelope where it catalyzes ubiquitination of nuclear substrates (107). Hrd1 is 
stabilized by formation of a complex with Hrd3, another ER resident membrane protein. 
Hrd3 contains a large luminal domain which is thought to be involved in substrate 
sensing of luminal lesions and is required for ERAD of both soluble and polytopic 
membrane proteins (108).  With the E2 ubiquitin conjugating enzyme, Ubc7 which is 
tethered to the ER membrane via Cue1, Hrd1 catalyzes the ubiquitination of ERAD 
substrates with membrane or luminal lesions (109). Ubc1, another E2 ubiquitin 
conjugating enzyme, has also been implicated in Hrd1 catalyzed ubiquitination of the 
mutant vacuolar enzyme, carboxy-peptidase yscY-S255R, commonly known as CPY* 
(110).  On the other hand, ERAD substrates with cytoplasmic lesions, or unassembled 
subunits of oligomeric complexes are ubiquitinated by Doa10. Doa10 dependent 
ubiquitination requires the Ubc7/Cue complex and to a lesser extent the tail anchored 
Ubc6 (111). One of the best studied Doa10 substrates is a truncated mutant of the Ste6 
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ATP-binding cassette (ABC) transporter of the pheromone, alpha factor, denoted as 
Ste6*. Normally, wildtype Ste6 is slowly internalized from the cell surface and targeted 
for vacuolar degradation by ubiquitin-mediated endocytosis (112), however a truncation 
of the Ste6 C-terminal cytosolic tail results in rapid degradation by ERAD with a half-life 
of less than 10 min (113).   
According to sequence homology, two human Hrd1 homologues (HRD1 and 
gp78) and one Doa10 homologue (TEB4) have been identified. The mammalian 
homologues of yeast Ubc6 and Ubc7 are MmUbc6 and MmUbc7, respectively. Like 
yeast Ubc6, MmUbc6 is anchored to the ER by a C-terminal membrane domain. 
However a Cue1 homologue has not been identified in mammals. Instead MmUbc7 is 
recruited to the ER by a Cue domain already present within gp78 (114).   
1.4.5. Substrate Extraction and Delivery to the Proteasome. Following 
ubiquitination, a series of ubiquitin-binding proteins escort modified substrates from the 
ER to the proteasome. One of these factors is the AAA ATPase, Cdc48 (p97 in 
mammals) which along with its cofactors (Ufd1 and NpI4) is involved in substrate 
extraction and escort of ubiquitinated substrates to the proteasome. Cdc48 is recruited to 
the ER membrane by the integral membrane protein, Ubx2 (115).  The Cdc48 complex 
binds oligo-ubiquitinated substrates as well as Ufd2, an E4 multiubiquitination enzyme 
which further extends ubiquitin chains to aid in proteasomal recognition (116). 
Polyubiquitinated substrates are recognized by the ubiquitin chain receptors, Rad23 and 
Dsk2, which also bind Ufd2 in a Cdc48 dependent manner. Rad23 and Dsk2 share 
overlapping properties since ERAD defects are only apparent in a Δdsk2 Δrad23 double 
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mutant. Png1p, an N-glycanase that discriminates between correctly folded and mis-
folded glycoproteins is also recruited to the proteasome via Rad23 in order to remove 
glycans from glycosylated ERAD substrates prior to proteasomal degradation (117). In 
some instances the proteasome itself has been attributed to extraction of substrates from 
the ER. The 19S regulatory particle contains six AAA-ATPases that could also provide 
the energy for extraction of some ERAD substrates. For example in yeast a mutant of 
pro-alpha factor (pαF*) is not ubiquitinated and the 19S regulatory particle is the only 
cytosolic factor required for export from the ER in vitro (88). A significant fraction of 
proteasomes in the cell are associated with the ER suggesting that extraction and 
degradation is a tightly coupled process (118). 
1.4.6. Regulation of Protein Expression by the ERAD Pathway. In addition to 
performing a strict quality control role, ERAD can be harnessed for regulated degradation 
of select proteins in response to cellular signals. While quality control mechanisms 
recognize common structural hallmarks of non-native proteins, short target sequences 
called degrons can target naturally expressed proteins for degradation.  Under certain 
conditions, proteins may display degrons that are recognized by the ER quality control 
system and are degraded. These can be masked upon signal sensing which allows escape 
from ERAD. Degrons which are recognized by the ERAD machinery have been 
described for cytosolic, ER resident and secretory proteins in both yeast and mammals. 
In yeast ubiquitination of the cytosolic/nuclear localized transcriptional repressor 
MATα2 is dependent upon the ER-resident Ubc6 and Ubc7 E2 conjugating enzymes and 
the Doa10 E3 ubiquitin ligase (119,120). A transplantable 67 amino acid degradation  
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signal designated Deg1, targets MATα2 for Doa10 ubiquitination and proteasomal 
degradation. A ~19 residue determinant within Deg1 appears to be crucial for recognition 
and degradation. Deg1 is predicted to form an amphipathic helix in which a hydrophobic 
face appears to be the most critical recognition determinant (121). Heterodimerization of 
Figure 1.5.  Molecular Factors Involved in Yeast ERAD. ERAD-L substrates are 
recognized by ER lumenal Hsp70/Hsp40 chaperones (Kar2, Jem1 and Scj1), PDI, 
putative lectins (Yos9 and Htm1/Mnl1) and the lumenal domain of Hrd3. ERAD-C 
substrates are recognized by cytosolic Hsp70/Hsp40 chaperones (Ssa1, Ydj1 and 
Hlj1) and the Doa10 E3 ligase. ERAD-M substrates may be directly recognized by 
the Hrd1 E3 ligase. Ubiquitination of ERAD-L and ERAD-M substrates require 
Hrd1 while Doa10 is the ubiquitin ligase of ERAD-C substrates. The Ufd2 E4 ligase 
may be involved ubiquitin chain extension of some substrates. Extraction and 
proteasome delivery of membrane substrates requires the AAA ATPase, Cdc48 and 
its Ubx2 membrane anchor. The ubiquitin binding proteins Rad23 and Dsk2 play a 
role in proteasomal recruitment. Ubiquitin moieties are removed by a series of de-
ubiquitinating enzymes (DUBs) that may include Rpn1, and/or Otu1. Glycans are 
removed from glycosylated substrates by Png1. Red star depicts misfolding or 
degradation signals that lead to entry into the ERAD degradation pathway. Figure 
adapted from (93). 
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MATα2 with its binding partner, MATa1 masks the Deg1 signal resulting in its 
stabilization.  
A series of Doa10 recognized degrons were identified in a selection of genomic 
sequences which destabilized the stable cytosolic protein, Ura3 (122). One of these 
artificial degrons identified is CL1, a 16 amino acid sequence (ACKNWFSSLSHGVIHL) 
also predicted to form an amphipathic helix and like Deg1 requires patches of bulky 
hydrophobic residues (123). A similar amphipathic helical structure targets serum and 
glucocorticoid-induced kinase 1 (SGK1) to an ER-resident E3 ligase for ubiquitination 
and degradation in mammals (124). Together these observations suggest that surface 
exposed hydrophobic residues which are normally buried in native proteins can serve as a 
recognition motif for ERAD.  
In mammals, secretion of the cholesterol and triglyceride carrier protein, 
apoliprotein B100 (ApoB) is also regulated by components of ERAD pathway. A 
significant portion of newly synthesized ApoB is degraded by both proteasomal and non-
proteasomal pathways, which are regulated by metabolic factors. When conditions are 
not favorable for ApoB assembly with lipids, ApoB is ubiquitinated and degraded by the 
proteasome (125). This process is facilitated by cytosolic chaperones of the hsp70 and 
hsp90 class during ER translocation (125). It has been proposed that ApoB is targeted to 
the ERAD machinery co-translationally while still bound to the ribosome. In this model 
efficient translocation of ApoB into the ER lumen is dependent on microsomal 
triglyceride transfer protein (MTP) dependent lipid transfer to the nascent polypeptide 
(126). The stalling of translocation leads to prolonged exposure of hydrophobic domains 
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within ApoB to the cytosol for recognition by components of the Ub-proteasome 
pathway. 
 The ER resident HMG-CoA reductase (HMGR) is the rate limiting enzyme of the 
mevalonate pathway by which cholesterol and a variety of isoprenoids are synthesized.  
The degradation of HMGR and its yeast homologue, Hmg2, are physiologically regulated 
by sterols (127-130).  When sterol flux is high, HMGR is targeted for ERAD in order to 
decrease enzyme levels. When flux is low, HMGR circumvents ERAD, and enzyme 
levels increase. Hrd1 (HMG-CoA reductase degradation) with its E2 partners Ubc1 and 
Ubc7 mediate the ubiquitination and degradation of Hmg2 in yeast (131,132). Gp78, the 
mammalian orthologue of Hrd1 was later identified as the ubiquitin ligase of HMGR 
(133). It is not surprising that ER resident proteins like HMGR/Hmg2 are degraded by 
ERAD machinery that also resides in the ER. The molecular signal for yeast Hmg2 
degradation is derived from farnesyl pyrophosphate (FPP), an intermediate in the 
mevalonic acid pathway. In the presence of FPP, Hmg2 acquires structural features of a 
misfolded protein as indicated by increased susceptibility to proteolysis which is reversed 
by chemical chaperones such as glycerol (134).  The N-terminal transmembrane domain 
of Hmg2 is both necessary and sufficient for sterol mediated regulation and fusion of this 
domain can impart regulation of other stable proteins (135). The details regarding the 
nature of the recognition signal within Hmg2 are not known but mapping studies have 
uncovered a distributed degron where structural information required for recognition is 
dispersed throughout the first N-terminal transmembrane domain (135). More recently, 
two yeast ER membrane anchored chaperone proteins, NSG1 and NSG2 were shown to 
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be involved in the stabilization of Hmg2 through interaction with the sterol sensing N-
terminal domain (136). Further studies of the human orthologue, Insig-1, demonstrated 
that sterol induced binding of Insig-1 to the sterol sensing domain of HGMR, leads to 
recruitment to the ubiquitin ligase, gp78 (133). Thus, it appears that other adaptor 
proteins can contribute to the specificity of ER resident ubiquitin ligases. 
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2.1. Abstract 
Detoxification and homeostatic acquisition of metal ions are vital for all living 
organisms. We have identified PCA1 in yeast S. cerevisiae as an overexpression 
suppressor of Cu toxicity. PCA1 possesses signatures of a P1B-type heavy metal 
transporting ATPase which is widely distributed from bacteria to humans. Cu resistance 
conferred by PCA1 is not dependent on catalytic activity, but it appears that a cysteine-
rich region located in the amino-terminus sequesters Cu. Unexpectedly, when compared 
to two independent natural isolates and an industrial S. cerevisiae strain, the PCA1 allele 
of common laboratory strains we have examined possesses a missense mutation in a 
predicted ATP-binding residue conserved in P1B-type ATPases. Consistent to a previous 
report which identifies an equivalent mutation in a Cu transporting P1B-type ATPase of a 
Wilson disease patient, the PCA1 allele found in laboratory yeast strains is non-
functional. Overexpression or deletion of the functional allele in yeast demonstrates that 
PCA1 is a Cd efflux pump. Cd as well as Cu and Ag, but not other metals examined, 
dramatically increase PCA1 protein expression through post-transcriptional regulation 
and promote subcellular localization to the plasma membrane. Our study has revealed a 
novel metal detoxification mechanism in yeast mediated by a P1B-type ATPase that is 
unique in structure, substrate specificity and mode of regulation. 
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2.2. Introduction.   
Excretion and detoxification of non-physiological metals, homeostatic absorption and 
utilization of nutritional yet toxic metals are fundamental biological processes. Metal 
toxicity and deficiency resulting from defects in metabolism and excess accumulation 
through environmental contamination are implicated in a number of disorders, including 
failure in normal growth and development, and initiation and progression of degenerative 
diseases (1-7). For instance, a genetic defect in copper (Cu) excretion in the liver leads to 
Wilson disease exhibiting hepatic failure and neuronal dysfunctions (7). Cadmium (Cd) is 
a well-known industrial and environmental pollutant implicated in cancer, neurological 
disorders, reproductive defects, and endocrine disruption (8-12). Cd exerts its toxic 
effects by the perturbation of cellular redox balance, inhibition of DNA repair, disruption 
of metal ion homeostasis, and alterations in signal transduction (8-12). Mechanistic 
insights into metal metabolism in living organisms would facilitate prevention and 
treatment of metal-related disorders and to develop methods for efficient remediation of 
toxic metals from the environment.  
Organisms have evolved defense mechanisms to combat the toxic effects of heavy 
metal ions. The P1B-type ATPase family of heavy metal transporters that are distributed 
from bacteria to humans extrude toxic metal ions such as Cu, Ag, Zn, Co, Pb and/or Cd 
from the cell (13-18). Functional characterization of this family of transporters has 
supported the conclusion that efflux mechanisms play critical roles in metal 
detoxification in bacterial cells (13-15). Cu-specific P1B-type ATPases have been 
identified in eukaryotes as well (2,7,16,17). Cloning of genes defective in Menkes and 
44 
Wilson disease have revealed that two P1B-type ATPases (ATP7a and ATP7b) play 
essential roles in Cu acquisition and excretion in humans (2,7,16). Plants express Cu, Zn, 
Co, Pb and/or Cd-translocating ATPases that appear to be involved in distribution and 
compartmentalization of these metal ions (17,18).  
While metal efflux systems have begun to be characterized (16-24), it has been 
suggested that in eukaryotes metallothionine (MT), a Cys-rich low-molecular-weight 
protein, and glutathione (GSH)-mediated sequestration appears to be the major 
mechanism in neutralizing toxic metals (25-29). Ycf1 in S. cerevisiae, a vacuolar 
membrane ATP-binding cassette (ABC) transporter, sequesters glutathione-conjugated 
Cd (30). Phytochelatin, a GSH polymer synthesized in plants and yeast S. pombe also 
detoxifies heavy metals (27). Metal-responsive transcription factor 1 (MTF-1) regulates 
basal and metal-inducible expression of MTs and other genes in mammals, fruit fly, and 
fish (31-34). In contrast to mammalian genes encoding MT, Cu but not Cd and Zn 
induces the Cup1 gene in S. cerevisiae through the ACE1 transcription regulator (35,36). 
Consistent to their critical roles in induction of the genes involved in metal detoxification, 
deletion of MTF1 in mice and ACE1 in S. cerevisiae, results in enhanced metal sensitivity 
(32,35).  
In order to gain better insights into the mechanisms of heavy metal metabolism, 
we have selected S. cerevisiae cDNAs that suppress Cu sensitivity of the ace1Δ yeast 
strain. One of the cDNAs identified encodes the putative P1B-type ATPase, PCA1, which 
has been suggested to be involved in Cu and/or Fe homeostasis (37,38). Previously, the 
Cd resistance of a mutant yeast strain selected on toxic concentrations of Cd was mapped 
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to the PCA1 gene which contained multiple mutations (39). However, the role and 
mechanisms of action of PCA1 in metal metabolism have remained elusive. Here we 
show that PCA1-mediated Cu resistance is dependent on its Cys-rich amino terminal 
domain. The PCA1 allele in all laboratory yeast strains examined carries a missense 
mutation in a conserved residue resulting in loss of function. The wild-type PCA1 allele 
confers Cd resistance by an efflux mechanism accompanied by a novel mode of metal-
dependent post-transcriptional regulation. 
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2.3. Experimental Procedures 
2.3.1. Yeast Strains, Media, and Phenotypic Tests. Strain BY4741 (MATa 
his3∆1 leu2∆0 met15∆0 ura3∆0) and null mutants ace1Δ::KanMX6, pca1Δ::KanMX6 
were purchased from Open Biosystems. Strain RM11-1a (40) (MATa leu2∆0 ura3∆0 
HO::KanMX6) was kindly provided by Leonid Kruglyak (Fred Hutchison Cancer 
Research Center, Seattle, WA). RM11-1a pca1Δ::URA3 and BY4741 ace1Δ::KanMX6 
Δpca1:HIS3 were generated by PCR based homologous recombination (41). For 
consistency and simultaneous comparisons of Cu and Cd sensitivity, all experiments 
unless indicated otherwise were performed using the BY4741 ace1Δ strain. Plasmids 
were transformed into yeast using the lithium acetate procedure (42). Yeast cells were 
grown on synthetic complete (SC) media (2 % dextrose or galactose, 0.67 % yeast 
nitrogen base, and 0.2 % dropout mixture for plasmid selection). For phenotypical 
analysis, ~5 μl of yeast cells (OD600 1.0) were spotted on selective media (1.5 % agar) 
supplemented with the indicated concentrations of Cd (CdCl2) or Cu (CuCl2) (Sigma) and 
incubated at 30 °C for 2 days. 
2.3.2. Selection of cDNAs Conferring Cu Resistance. Strain BY4741 ace1Δ 
strain was transformed with a yeast cDNA library (43). Transformants (~1x106 colonies) 
growing on SC-Ura media were collected by re-suspending in sterilized distilled water, 
diluted, and plated on galactose-containing SC-Ura media supplemented with Cu (0.1 
mM CuCl2). Plasmids containing cDNA were isolated from yeast colonies growing on 
selection media and identified by sequencing. cDNA-dependent Cu resistance was 
confirmed by re-transformation of the isolated plasmid into ace1Δ yeast cells. 
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2.3.3. Plasmid Construction.  The PCA1 ORF (open reading frame) was PCR 
amplified from yeast genomic DNA and cloned into BamHI and XhoI restriction sites of a 
single-copy yeast expression vector for GPD (p413 GPD) (44) or GAL1 (p413 GAL1) 
(45) gene promoter-mediated constitutive expression. The coding sequence of the PCA1 
N-terminal domains (aa 1-392 and 1-452) were PCR amplified with a primer set 
containing a start codon and artificially generated stop codon, and subcloned into BamHI 
and EcoRI sites of p413-GPD. The PCA1 truncation mutant (aa 393-1216) was generated 
by PCR amplification of the sequences including start and stop codons, and was 
subcloned into p413 GPD at BamHI and XhoI restriction sites. PCA1-GFP and PCA1-
Flag were constructed by generation of a NotI restriction site after the start codon for 
insertion of NotI flanked GFP (green fluorescent protein) without start and stop codons or 
two tandem Flag epitopes, respectively. For natural promoter driven expression, the 
PCA1 ORF including 810 bp upstream of the start position was cloned into SacI and XhoI 
restriction sites of plasmid pRS413 (46). Site-directed mutagenesis was conducted by the 
primer overlap extension method (47). All constructs were confirmed by sequencing. 
2.3.4. Fluorescence Microscopy. Yeast cells were transformed with PCA1-GFP 
or PCA1-WT-GFP expression plasmids and cultured in SC-His media at 30 °C with 
agitation until mid-log phase. Metals were added to the culture media for 15 min to 2 hrs 
prior to imaging. Cells were collected, washed in phosphate-buffered saline (PBS) and 
imaged on a confocal microscope (Olympus FV500). 
2.3.5. Metal Measurements. Yeast cells were cultured until mid-log phase and 
metal ions were added to the culture media for 6 hours. Cells were collected in 2 mL 
48 
aliquots and washed two times in PBS containing 10 mM EDTA. Cell pellets were 
dissolved in 70 % nitric acid at 60 °C for 30 min and diluted to 10 % nitric acid. To 
measure Cd excretion, cells were cultured with  5 mM CdCl2 for 30 min, washed two 
times in PBS containing 10 mM EDTA, and re-suspended in fresh media prior to sample 
collection at the indicated time points. Total cellular metal levels were measured by 
inductively coupled plasma mass spectrometry (ICPMS) at the Department of Geological 
Sciences, University of Michigan. 
2.3.6. Immunoblotting. Total protein extracts were prepared from yeast cells 
using glass beads and triton X-100 (1 %) as described previously (48). Protein 
concentrations were measured by the BCA method (Pierce) according to the 
manufacturer’s specifications. Protein samples were resolved by reducing SDS-PAGE 
and transferred to a nitrocellulose membrane. PCA1-GFP was detected by 
chemiluminescence using a primary rabbit anti-GFP polyclonal antibody (1:2000) (Santa 
Cruz Biotechnology INC.) and secondary goat anti-rabbit HRP-conjugated antibody 
(1:5000) (Santa Cruz Biotechnology INC.). PCA1-Flag was probed with primary mouse 
anti-Flag M2 monoclonal antibody (1:1000) (Sigma) and secondary sheep anti-mouse 
IgG HRP-conjugated antibody (Amersham) (1:5000). Loading control, phosphoglycerate 
kinase (PGK), was detected by chemiluminescence using mouse monoclonal anti-PGK 
antibodies (1:4,000) (Molecular Probes) and secondary sheep anti-mouse IgG HRP-
conjugated antibody (1:5,000) (Amersham). 
2.3.7. Northern Blotting. Yeast cells were cultured until mid-log phase and 
supplemented with either 50 μM CdCl2 or 50 μM CuCl2 for 15 and 60 min. Total RNA 
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was extracted from cells and 25 ug was separated on an RNA gel (0.75 % agarose and 2 
% formaldehyde) and transferred to a nitrocellulose membrane (Protran). Gene specific 
DNA probes labeled with [α-32P]dCTP (Amersham) were generated using the random 
primer labeling system (Invitrogen). Hybridization of radio-labeled probes with RNA 
transcripts was performed by previously described methods (49). Relative mRNA levels 
were detected by autoradiography. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
2.4. Results 
2.4.1. The PCA1 N-terminal domain confers Cu resistance in yeast. To 
identify new factors involved in heavy metal defense, we carried out a selection of S. 
cerevisiae cDNAs that suppress lethality of the ace1Δ yeast strain on toxic Cu media. A 
cDNA encoding PCA1, one of two P1B-type ATPases in the S. cerevisiae genome 
(37,50), was identified. Yeast GPD gene promoter-driven constitutive expression of 
PCA1 confers resistance in the ace1Δ strain to Cu (0.1 mM CuCl2) compared to empty 
vector transformed control cells (Fig. 1A). Deletion of PCA1 in the ace1Δ strain resulted 
in a slight increase in sensitivity to Cu toxicity (Fig. 2.1A).  However, in a wild-type 
strain, Cu resistance was not easily discernable upon either over-expression or deletion of 
PCA1 (data not shown).  
 PCA1 contains all of the conserved features of the P1B-type ATPase family which 
is specific for heavy metal transport (16-18,51) (Fig. 2.1B). These features include eight 
predicted transmembrane domains, where an intramembranous metal-transporting CPx 
motif is located in the sixth trans-membrane domain (Fig. 2.1B). The catalytic domains 
reside within cytosolic loops which include the nucleotide binding domain (N-domain) 
and the phosphorylation domain (P-domain) (Fig. 2.1B).  PCA1 contains a single CxxC 
heavy metal binding motif located within the N-terminal region. An intriguing feature of 
PCA1 compared with other P1B-type ATPases is a Cys-rich N-terminal extension ~550 
amino acids before the first trans-membrane domain (Fig. 2.1B). In order to ascertain 
whether the observed Cu resistance by PCA1 is dependent on ATPase function, we 
carried out site-directed mutagenesis of conserved residues of this family of proteins and 
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assayed for Cu sensitivity. However, Cu resistance remained unchanged in all mutants 
(Fig. 2.1C), suggesting that Cu resistance is not dependent on metal translocation. Given 
that the N-terminus contains several cysteine residues (33 Cys), which could serve as Cu 
ligands, we tested whether this domain could independently confer resistance. A peptide 
corresponding to amino acid residues 1-452 which includes the CxxC motif (Fig.2.1B) 
was expressed in the ace1Δ strain. Expression of this peptide resulted in Cu resistance 
above that of full-length PCA1, presumably by chelating Cu ions in a manner analogous 
to MT (Fig. 2.1D). Cu resistance is maintained even after mutation of the conserved 
CxxC motif (C421A, C423A) (Fig. 2.1D) implying the existence of other Cu 
coordination site(s) in addition to this well-characterized metal-binding motif.  
2.4.2. Common laboratory yeast strains possess a G970R mutation in PCA1. 
S288c is a commonly used S. cerevisiae haploid strain in which its entire genome has 
been sequenced (52). Comparisons of the PCA1 sequence of S288c with natural isolates, 
RM11-1a (40) and YJM789 (53), using BLAST (NCBI, 
http://www.ncbi.nlm.nih.gov/blast/) revealed that the S288c strain carries a single 
nucleotide change in the PCA1 gene, which results in a G970R substitution. (Fig. 2.2). 
Our sequencing results of PCA1 cloned from the RM11-1a strain as well as an industrial 
baker’s yeast strain (Fleischmann’s) confirmed the G970R substitution. In order to 
determine if this mutation was unique to the S288c strain, we sequenced the PCA1 ORF 
of several laboratory yeast strains, BY4741 (Open Biosystems), DTY1 (54), EG103 (55), 
SKY9 (56), and YPH98 (46). All contained the G970R mutation (data not shown), which 
suggests a common lineage among theses strains. Furthermore, sequence alignments of  
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Figure 2.1. Cu resistance is mediated by the Cys-rich N-terminal domain of 
PCA1. A, PCA1 over-expression confers Cu resistance. BY4741 ace1Δ transformed 
with empty vector (p413-GPD) or PCA1 expression vector and BY4741 ace1Δ 
pca1Δ yeast cells were cultured in SC (SC-His) media and spotted on solid media 
supplemented with Cu (CuCl2) at the indicated concentrations. B, Schematic 
depiction of PCA1 sequence features. PCA1 contains the signatures of a P1B-type 
ATPase, eight predicted transmembrane domains (black boxes), intra-membranous 
CPx motif within the sixth transmembrane domain, a CxxC metal binding domain, a 
phosphorylation domain (P), and a nucleotide-binding domain (N). The N-terminal 
Cys-rich domain is shaded gray. Conserved residues that have been mutated for 
characterization are indicated under each domain. C, Cu resistance conferred by 
PCA1 is not dependent on metal translocation. BY4741 ace1Δ cells transformed with 
empty vector, a PCA1 expression vector or PCA1 with mutations in the CxxC motif 
(C421A and C424A), the CPx motif (C859A), or the aspartyl phosphorylation 
residue (D903A) were spotted on SC-His media with or without Cu supplementation. 
D, Cu resistance is conferred by the PCA1 N-terminus. Cells expressing empty 
vector, PCA1, PCA1 residues 1-452, or PCA1 residues 1-452 with site-directed 
mutations of the predicted metal-binding cysteines (C421A, C424A) were spotted on 
SC-His media with or without Cu supplementation. 
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Figure 2.2. Yeast laboratory strains contain a G970R mutation in PCA1. A 
region of the predicted nucleotide binding domain (N-domain) of PCA1 from strains 
S288c, RM11-1a and YJM789 were aligned with the corresponding region of other 
P1B-type ATPases, including human Cu-transporting ATP7a and ATP7b, S. 
cerevisiae CCC2, A. thaliana HMA4, S. auereous CadA, and A. fulgidus CopA. 
Boxes highlight conserved residues. Asterisk marks G970R substitution identified in 
the S288c and other laboratory S. cerevisiae strains. Sequences were obtained from 
data bases at The National Center for Biotechnological Information (NCBI) and 
alignments were performed with ClustalX (1.81).  
 
prokaryotic, yeast, plant and human P1B-Type ATPases show that this Gly residue is 
invariantly conserved among this family of proteins (Fig. 2.2). Recently, structural 
studies of the nucleotide binding domain (N-domain) of two P1B-type ATPases (CopA 
and ATP7b) places this Gly residue within an ATP binding pocket (57,58). The 
functional importance of this residue is further underscored by an equivalent G1101R 
substitution in ATP7b previously reported in patients with Wilson disease (59). Together, 
our data along with recent reports strongly support the conclusion that many laboratory S. 
cerevisiae strains contain a mutation of a critical residue in PCA1 that may play essential 
roles in function, expression, and/or regulation. 
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2.4.3. PCA1 natural allele confers hyper-resistance to Cd. To characterize the 
function of PCA1, we expressed the natural allele (PCA1-WT) and the G970R mutant 
allele (PCA1) in a laboratory yeast strain and examined metal tolerance. Indeed, 
expression of PCA1-WT allows cells to grow on media containing a Cd concentration 
over ten-fold higher compared to vector and PCA1 carrying the G970R mutation. 
(Fig.2.3A). However, growth on media supplemented with Cu was indistinguishable, 
which is consistent for Cu resistance being dependent on metal binding rather than 
ATPase activity (Fig. 2.3A). No growth advantages in cells expressing PCA1-WT were 
observed when toxic concentrations of Zn, Mn, Co or Fe were added to growth media 
(data not shown), suggesting specificity in metal binding and translocation by PCA1-WT.  
Since the RM11-1a strain contains a functional PCA1 allele, it would be predicted 
that this strain is more resistant to Cd compared to laboratory strains. Cd sensitivity was 
compared between the RM11-1a strain and our BY4741 laboratory strain. Indeed, the 
BY4741 strain is much more sensitive to Cd (Fig 2.3B). Deletion of PCA1-WT in the 
RM11-1a strain reduces Cd resistance compared to control cells (Fig. 2.3B) underscoring 
its significance in Cd defense. Cd tolerance returns to wild-type levels in the RM11-1a 
pca1Δ strain transformed with a natural promoter driven PCA1-WT plasmid confirming 
that Cd sensitivity was specific for deletion of PCA1-WT (Fig. 2.3B). As expected 
deletion of the non-functional PCA1 in the BY4741 strain did not significantly affect Cd 
resistance. However, introduction of PCA1-WT under control of its natural promoter 
rescued growth on Cd media (Fig. 2.3B). Interestingly, the RM11-1a strain displayed a  
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Figure 2.3.  PCA1 natural allele (PCA1-WT) plays a critical role in Cd defense.  A, 
PCA1-WT confers resistance to Cd toxicity. BY4741 ace1Δ cells expressing PCA1 cloned 
from a laboratory strain (PCA1) or natural isolate (PCA1-WT) under control of a 
constitutive promoter of the GPD gene were spotted on SC-His media supplemented with 
CuCl2 or CdCl2 at the indicated concentrations. B, PCA1-WT plays a physiological role in 
Cd defense. Cd resistance of laboratory strain BY4741 (BY) was compared to natural 
isolate RM11-1a (RM). Wild type BY and RM strains or Δpca1 null mutants were 
transformed with empty vector or PCA1-WT under control of its natural promoter. Cells 
were spotted on SC-Leu media supplemented with CdCl2 at indicated concentrations. C, Cd 
resistance conferred by PCA1-WT is dependent on P1B-type ATPase catalytic activity. 
Amino acid substitutions in PCA1-WT were made in the amino terminal CxxC motif 
(C421A and C424A), the CPx motif (C859A), or the aspartyl phosphorylation residue 
(D903A). Cells expressing PCA1-WT or mutants were spotted on SC-His media 
supplemented with indicated concentrations of CdCl2. D, The Cys-rich N-terminus of 
PCA1-WT is not essential for Cd resistance. BY4741 ace1Δ cells expressing empty vector, 
PCA1-WT, PCA1 ( 1-392) and truncated PCA1-WT (393-1216) were spotted on SC-His 
solid media supplemented with the indicated concentrations of CuCl2 or CdCl2. 
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Cd growth advantage over the BY4741 strain when PCA1-WT is null-mutated, implying 
that there may be other factor(s) contributing to Cd resistance (Fig. 2.3B). 
 We then asked whether Cd resistance is coupled with active metal transport of a 
P1B-type ATPase. Site-directed mutagenesis of conserved amino acids among P1B-type 
ATPases, including the CxxC motif (C421, C424), the CPx motif (C859), and the 
phosphorylation site (D903), completely abolished Cd resistance (Fig. 2.3C). These 
results suggest that Cd resistance is dependent on an active metal transport mechanism.  
2.4.4. The Cys-rich N-terminal domain of PCA1 is not essential for Cd 
resistance. PCA1 carries a Cys-rich N-terminal domain that does not have significant 
sequence homology with any characterized metal-binding protein. We examined the role 
of this domain in Cd resistance by expressing the N-terminal 392 amino acid domain and 
a truncation PCA1-WT allele lacking this domain. The truncated PCA1-WT allele (aa 
393-1216) includes the CxxC motif since it is critical for Cd resistance (Fig. 2.3C). Cells 
expressing the N-terminal 392 amino acid peptide are more resistant to both Cd and Cu 
compared with empty vector-transformed cells (Fig. 2.3D).  Truncation of this N-terminal 
domain did not significantly affect Cd resistance as compared to full length PCA1-WT 
(Fig. 2.3D). These data suggest that the Cys-rich N-terminal domain itself reduces Cu and 
Cd toxicity, but is not critical for Cd transport. In contrast, Cu resistance conferred by 
PCA1-WT was abolished in the truncated mutant (Fig. 2.3D), which further supports the 
conclusion that Cu resistance conferred by PCA1 is not dependent on ATPase activity but 
rather metal sequestration by this domain. 
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2.4.5. PCA1-mediated Cd export. We addressed three different possible 
mechanisms governing PCA1-WT mediated Cd resistance. First, PCA1-WT could be 
involved in Cd sequestration and/or compartmentalization to intracellular organelles. To 
test this possibility, total cellular Cd levels were measured by inductively coupled plasma 
mass spectrometry (ICPMS) of cells expressing empty vector, PCA1 or PCA1-WT when 
cultured in Cd supplemented media. Cells expressing PCA1-WT as compared to empty 
vector and PCA1 displayed a marked decrease in total cellular Cd accumulation (Fig. 
2.4A). These results indicate that PCA1-WT either reduces Cd uptake or enhances efflux. 
Second, to address the possibility that PCA1-WT may indirectly reduce cellular Cd 
uptake, yeast cells expressing empty vector or GAL1 promoter-mediated expression of 
PCA1-WT were pre-treated with toxic amounts of Cd under glucose repression. Cells 
were then washed to remove extracellular Cd and spotted on solid SC media containing 
either glucose or galactose. Empty vector-transformed cells and PCA1-WT displayed 
similar growth under glucose repression (Fig. 4B). However, cells expressing PCA1-WT 
displayed an obvious growth advantage on galactose media in which PCA1-WT is 
expressed (Fig. 2.4B). Since PCA1-WT expression was repressed during Cd exposure its 
role in Cd defense must occur after Cd has already entered the cell. Third, to conclusively 
demonstrate an active efflux role, yeast cells were pre-treated with Cd, washed to remove 
extracellular Cd, re-suspended in fresh media, and collected at 30 min intervals to 
determine cellular Cd content.  Cd levels in cells expressing empty vector remained 
relatively constant for 60 min after Cd removal (Fig. 2.4C and inset). In contrast, Cd 
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levels rapidly declined in cells expressing PCA1-WT (Fig. 2.4C and inset). All together, 
these data strongly support the conclusion that PCA1-WT functions as a Cd efflux pump. 
2.4.6. Metal-dependent regulation of PCA1 expression. Since Cd concentration 
in the environment likely fluctuates, it is reasonable to predict that Cd regulates PCA1 
expression.  However, Northern blot analysis did not indicate any induction of the PCA1 
gene after the addition of either Cd or Cu to culture media (Fig. 2.5A). Both Cd and Cu 
induced GSH1 encoding an enzyme required for GSH synthesis under the same 
experimental conditions (Fig. 2.5A). We next examined the possibility of post-
transcriptional regulation. Total protein extracts from cells expressing N-terminal Flag 
epitope-tagged PCA1-WT were subjected to Western blot analysis. PCA1-WT-Flag and 
non-tagged PCA1-WT exhibit indistinguishable Cd resistance indicating that epitope 
tagging does not perturb function (data not shown).  Although PCA1-WT expression was 
mediated by a relatively strong GPD gene promoter, PCA1-WT-Flag was hardly 
detectable. However, Cd supplementation to culture media dramatically enhanced PCA1-
WT-Flag protein levels in a time and dose-dependent manner (Fig. 2.5B). Not only Cd 
but also Cu and Ag specifically increased PCA1-WT-Flag protein levels (Fig. 2.5C). 
Since the coding sequences of PCA1-WT were inserted into a vector for constitutive 
expression by a GPD gene promoter and CYC1 terminator, it is likely that Cd, Cu, and 
Ag stabilize PCA1 rather than regulate translation.  CCC2, a Cu-transporting P1B-type 
ATPase, inserted into the same vector, was not regulated by metal ions supporting the 
conclusion that the observed metal regulation of PCA1 is independent of the GPD 
promoter and/or CYC1 terminator (data not shown).  
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Figure 2.4.  PCA1-WT Cd resistance is dependent on an efflux mechanism. A, 
Over-expression of PCA1-WT reduces total cellular Cd content. BY4741 ace1Δ cells 
transformed with empty vector (p413-GPD) or  PCA1 or PCA1-WT expression 
vectors were cultured in SC-His media supplemented with Cd (50 μM CdCl2) for six 
hours. Cells were collected, washed, and total cellular Cd levels were measured by 
ICPMS. Bar graphs represent the average ±S.D. of four independent measurements. 
B, BY4741 ace1Δ cells were transformed with an expression plasmid of PCA1-WT 
under control of the GAL1 gene promoter or control plasmid. Cells were cultured in 
SC-His media supplemented with 1mM CdCl2 for 1 hr under glucose repression, 
washed, and spotted on SC-His media containing either glucose (Glu) or galactose 
(Gal). C, PCA1-WT enhances Cd efflux. BY4741 ace1Δ cells transformed with 
empty vector (closed circles) or a GPD promoter-mediated PCA1-WT expression 
vector (open circles). Cells were cultured in SC-His media supplemented with 
0.5mM CdCl2 for 30 min, washed and re-suspended in fresh media. Aliquots were 
collected at indicated time points and Cd levels were measured. Each data point 
represents the average ±S.D. of four independent samples. Inset indicates percent of 
initial Cd content. 
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Figure 2.5. Metal-dependent regulation of PCA1 expression. A, Cd and Cu do not 
induce transcription of PCA1. BY4741 ace1Δ cells were cultured in SC media 
supplemented with Cd (50 μM CdCl2) or Cu (50 μM CuCl2) for 15 or 60 min prior to 
total RNA extraction. Transcripts of PCA1, GSH1 (a positive control), and ACT1 (a 
loading control) were detected by Northern blot analysis using gene-specific 32P-
labeled probes. B, Post-transcriptional regulation of PCA1-WT. BY4741 ace1Δ cells 
transformed with PCA1-WT-Flag were cultured in SC-His media supplemented with 
Cd (1, 10 or 50 μM, CdCl2) for 120 min (left panel) or 50 μM CdCl2 (15, 30 or 120 
min) (right panel). PCA1-WT-Flag expression was detected by Western blot analysis. 
PGK (phosphoglycerate kinase) was probed as a loading control. C, Metal specific 
post-transcriptional regulation of PCA1-WT. BY4741 ace1Δ cells transformed with a 
PCA1-WT-Flag expression construct were cultured for 120 min in SC-His media 
supplemented with Cd (50 uM CdCl2), Cu (50 uM CuCl2), Ag (25 μM AgNO3), Co 
(4 mM CoSO4), Zn (15 mM ZnCl2), Fe (2 mM FeC6H5O7HCl), Mn (15 mM MnCl2), 
and Pb (0.2 mM Pb(NO3)2HCl). PCA1-WT-Flag expression was analyzed by 
Western blot using anti-Flag antibodies. PGK was probed as a loading control.  
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2.4.7. Subcellular localization of PCA1-WT. The function of PCA1-WT as a Cd 
efflux pump suggests that it is localized at the plasma membrane. To test this prediction, 
both PCA1-WT and PCA1 fused with GFP at the N-terminus were localized by confocal 
fluorescence microscopy. The Cd resistance conferred by tagged PCA1-WT-GFP and 
untagged PCA1-WT were indistinguishable (data not shown). Under normal conditions 
both PCA1 and PCA1-WT display faint fluorescent signals distributed throughout the 
cytoplasm (Fig. 2.6A). In accordance with the enhanced protein expression determined 
by Western blotting (Fig. 2.5B and 2.5C), the addition of Cd (Fig.  2.6A) as well as Cu 
and Ag (data not shown) to culture media dramatically enhanced fluorescent signal in 
cells. Furthermore, consistent with a predicted role in Cd efflux, PCA1-WT-GFP is 
primarily localized at the plasma membrane in the presence of Cd (Fig. 2.6A) as well as 
Cu and Ag (data not shown). Addition of Zn, Fe, Co, Pb, and Mn to the culture media 
had no significant effect on fluorescent signals for PCA1-WT-GFP or PCA1-GFP (data 
not shown). Expression of the non-functional PCA1-GFP was enhanced by Cd, however 
it did not properly localize to the plasma membrane (Fig. 2.6A, 2.6B), suggesting that the 
G970R mutation perturbs trafficking.  Western blot analysis of PCA1-GFP and PCA1-
WT-GFP detected a product of the predicted size (Fig. 2.6B), indicating that the GFP 
signal reflects full-length PCA1 protein. These data demonstrate that metal ions regulate 
PCA1-WT protein levels and stimulate plasma membrane localization.    
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Figure 2.6. Metal and functionality-dependent changes in subcellular 
distribution of PCA1.  A, Subcellular localization of wild-type and nonfunctional 
PCA1. BY4741 ace1Δ cells transformed with empty vector, PCA1-WT-GFP or 
PCA1-GFP were cultured to mid-log phase with or without Cd (50μM CdCl2) 
supplementation for 120 min. Cells were washed and fluorescence was visualized 
by confocal microscopy (left panels) and differential interference contrast  (right 
panels). B, Western analysis of PCA1-GFP fusion proteins. Total protein extracts 
were prepared from cells with or without Cd supplementation to the culture media 
and PCA1-WT-GFP or PCA1-GFP were detected by Western blot analysis using 
anti-GFP antibodies. PGK (phosphoglycerate kinase) was probed as a loading 
control. 
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2.5. Discussion 
The P-type ATPase family of integral membrane proteins translocates various 
ions and phospholipids across membranes using the chemical energy of ATP hydrolysis 
(15-18,51,60-62). Virtually all organisms rely on these transporters for maintaining a 
transmembrane gradient of various ions, which are vital for nutrient uptake, 
neurotransmission, signaling, and excretion of toxic metals (15-18,51,60-62). The P1B-
type ATPase specifically transports soft metals, such as Cu, Cd, Zn and Pb (13-18). Our 
data presented herein support the conclusion that PCA1, one of the two P1B-type 
ATPases in the S. cerevisiae genome, is a Cd efflux pump which is non-functional in all 
five laboratory yeast strains that we have examined. Metal-induced stabilization and 
distribution of PCA1 at the plasma membrane is likely an important mechanism of rapid 
response to excess Cd. This is a novel mode of regulation identified in this family of 
proteins. Function, structural features and metal-dependent regulation patterns of PCA1 
revealed important new insights into the classification, substrate specificities, 
mechanisms of action, and regulation of P1B-type ATPases. Moreover, this study also 
uncovered that S. cerevisiae laboratory strains that have been used widely as an 
outstanding model system in biomedical sciences does not mirror, at least in cellular Cd 
defense, the strains living in natural habitats.    
 PCA1 has been proposed and classified as a Cu-transporting P1B-type 
ATPase (37). However our data does not support a Cu-transporting function. Instead the 
Cys-rich N-terminal domain appears to be the contributing factor involved in Cu 
resistance. The abundant Cys residues may serve as ligands for Cu binding. Expression of 
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this domain itself confers Cu tolerance in yeast, which supports the hypothesis that these 
abundant Cys residues participate in metal coordination. However, detoxification of Cu-
generated reactive oxygen species (4) by this domain can not be excluded as superoxide 
dismutase activity has been reported for the similar Cys-rich MT (63). It is interesting to 
note that AtHMA2 and AtHMA4, two P1B-type ATPases of A. thaliana, possess a 
similar Cys/His-rich domain at the C-terminus (19,21,22). However, these domains do 
not show significant sequence identity with each other or with any other known metal-
binding proteins. It appears that this region is not essential for AtHMA2/4 function 
(64,65). Consistently, truncation of the Cys-rich N-terminal domain, excluding the CxxC 
motif, does not alter PCA1-WT mediated Cd resistance. This region may play regulatory 
roles through interaction with metals and/or with other proteins. Several Ca++-
transporting P-type ATPases were shown to carry autoinhibitory domains (51,60). 
Binding of regulators and phosphorylation of C-teminal residues of H+-transporting 
ATPases in plants has also been reported (51,61,66). We are currently testing the 
regulatory roles of the Cys-rich N-terminal domain of PCA1.  
A conserved signature of P1B-type ATPase family is the one to six CxxC motifs 
located within the N-terminal region (67). For instance, human ATP7a and ATP7b 
contain six such motifs. The two Cys residues bind a single Cu (Cu+) ion in a linear 
bicoordinate manner (68). While Cu binding to these motifs is firmly established by 
several methods, their roles in the function and regulation of ATP7a and ATP7b remain 
unclear. These motifs have been suggested to influence Cu translocation and/or 
subcellular trafficking of ATP7a and ATP7b (67). Site-directed mutagenesis of the CxxC 
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motif in PCA1 showed that the two Cys residues are necessary for Cd resistance, which 
suggests Cd binding to this domain is critical for PCA1 function. Cd coordination 
unlikely occurs through two Cys residues but rather with multiple ligands. Future metal 
binding studies and structural characterization of the Cys-rich domain would reveal how 
PCA1 coordinates Cd or other metal ions. Distinct structural features for metal 
coordination of this domain may explain substrate specificity of P1B-type ATPases. 
Given that the cytosolic Cu carrier, Atox1, directly interacts with the metal binding 
domain of ATP7a and ATP7b, PCA1 may acquire Cd from a carrier molecule. Since Cd 
binds thiol groups (25-29), glutathione and/or other cytosolic Cd carriers may specifically 
interact with the PCA1 metal binding domain to transfer Cd. For instance, YCF1, a 
vacuolar ABC transporter utilizes bis(glutathionato)Cd  as its substrate (30).   
P1B-type ATPases are categorized into several subfamilies depending on 
substrates and structural features (69), although the molecular determinant(s) for the 
substrate specificities is not known. Given that PCA1 deletion or over-expression 
specifically alters cellular accumulation and resistance of Cd, PCA1 appears to be the 
first Cd-specific P1B-type ATPase. It is possible that PCA1 may efflux other heavy metal 
ions but since they do not enhance protein expression, substrate specificity can not be 
deciphered by metal resistance. We have addressed this issue by the generation of a 
functional PCA1 mutant which is constitutively expressed even in the absence of Cd (D. 
Adle and J. Lee, unpublished data). Additionally, in vitro biochemical ATPase assays 
would further define PCA1 substrate specificity.  
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Sequence analysis of the PCA1 ORF of two independent natural strains, and an 
industrial strain clearly identified a G970R mutation to exist in all examined laboratory 
strains. Although a few other polymorphisms exist, all carried the G970R substitution. It 
is likely that the ancestral S. cerevisiae laboratory strain carrying the original G970R 
mutation was propagated to several research laboratories across the world. Interestingly, 
a PCA1 allele containing several (27 amino acid) missense mutations was identified in a 
yeast strain that was selected on media containing lethal concentrations of Cd (39). 
Among these mutations, an R970G mutation was implicated in Cd resistance conferred 
by the mutant PCA1 (39). Thus, it appears that in this report a non-functional PCA1 
mutant was reverted to the functional allele under Cd stress.  The non-functional PCA1 
allele, at least partially, explains Cd sensitivity of a laboratory strain (BY4741) compared 
with a natural isolate (RM11-1a). The RM11-1a strain was still hyper-resistant compared 
to BY4741 even when PCA1 was deleted in these strains, implicating the existence of 
other contributing factors involved in Cd defense. Elucidation of the underlying reason of 
Cd hyper-resistance in the RM11-1a strain would lead to a better understanding of 
mechanisms involved in Cd detoxification.   
Regulation of subcellular distribution and transcription of P1B-type ATPases 
have been previously reported, suggesting the significance of active regulation of this 
family of transporters. ATP7a and ATP7b localize to the ER-golgi membrane where they 
transport Cu across the membrane for incorporation into proteins in the secretory 
pathway (7,16,50,67). Excess cellular accumulation of Cu induces trafficking of ATP7a 
to the plasma membrane and ATP7b to cytoplasmic vesicles (67). In addition to post-
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translational regulation, several examples of metal-dependent transcriptional regulation 
of genes encoding P1B-type ATPases have been reported in plant, yeast, and bacteria 
(19,21,70-73). PCA1 mRNA levels are not regulated by Cd or Cu. However, Cd 
dramatically regulates PCA1 protein levels and promotes localization to the plasma 
membrane, which is a unique mode of regulation for this family of transporters.  
Interestingly, Cu and Ag also regulate PCA1 protein expression, although PCA1 does not 
transport these metals. Since the N-terminus of PCA1 possesses a Cys-rich region which 
likely binds Cu, it is plausible that metal binding to this domain controls turnover of 
PCA1.  
Given that the Gly970 residue in PCA1 is conserved among this family of 
proteins and has been positioned in an ATP binding pocket of two independent structures 
of P1B-type ATPases (58,74), it is likely that this residue is involved in ATP binding. 
Interestingly, the G970R mutant exhibits a distinct localization pattern compared with 
that of PCA1-WT. An equivalent mutation identified in ATP7b of Wilson disease 
patients might also lead to defects in subcellular distribution. A specific conformation 
resulting from ATP binding and metal translocation may determine proper trafficking of 
PCA1. This may occur through PCA1 conformation-dependent attraction of secretory 
and/or endocytosis machinery. We are currently exploring these possibilities. 
Cd is one of the most toxic environmental pollutants. It is removed slowly from 
the body, which may be due to high affinity binding to cellular ligands, such as thiol 
groups in proteins, glutathione, methallothionein, and cysteine. Cd transporters in 
hepatocytes and renal epithelial cells, such as ATP-binding cassette, multi-drug resistance 
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protein, GSH-Cd complex transporter, have been proposed to efflux GSH or Cys-
conjugated Cd (23,24). However, no report has identified other P1B-type ATPases in the 
human genome in addition to ATP7a and ATP7b. Further characterization of Cd efflux 
systems in higher eukaryotes would advance our ability to combat Cd-related disorders 
and develop methods for remediation of toxic heavy metals. 
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3.1. Abstract 
 Cadmium is a highly toxic environmental contaminant implicated in various 
diseases. Our previous data demonstrated that Pca1, a P1B-type ATPase, plays a critical 
role in cadmium resistance in yeast S. cerevisiae by extruding intracellular cadmium. 
This illustrates the first cadmium-specific efflux pump in eukaryotes. In response to 
cadmium, yeast cells rapidly enhance expression of Pca1 by a post-transcriptional 
mechanism. To gain mechanistic insights into the cadmium-dependent control of Pca1 
expression, we have characterized the pathway for Pca1 turnover and the mechanism of 
cadmium sensing that leads to up-regulation of Pca1. Pca1 is a short-lived protein (t1/2<5 
min) and is subject to ubiquitination when cells are growing in media lacking cadmium. 
Distinct from many plasma membrane transporters targeted to the vacuole for 
degradation via endocytosis, cells defective in this pathway did not stabilize Pca1. 
Rather, Pca1 turnover was dependent on the proteasome. These data suggest that, in the 
absence of cadmium, Pca1 is targeted for degradation before reaching the plasma 
membrane. Mapping of the N-terminus of Pca1 identified a metal-responding degradation 
signal encompassing amino acids 250 to 350. Fusion of this domain to a stable protein 
demonstrated that it functions autonomously in a metal-responsive manner. Cadmium 
sensing by cysteine residues within this domain circumvents ubiquitination and 
degradation of Pca1. These data reveal a new mechanism for substrate-mediated control 
of P1B-type ATPase expression. Cells have likely evolved this mode of regulation for a 
rapid and specific cellular response to cadmium.   
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3.2. Introduction 
While several heavy metals are essential micronutrients, many of them are toxic 
environmental contaminants with no physiological role. Genetic disorders in metal 
metabolism (e.g., hemochromatosis and Wilson disease) in which excess iron and copper 
are accumulated in the liver, respectively (1-3), provide striking evidence for the toxicity 
of nutritional metal ions. Cadmium is a highly toxic environmental contaminant linked to 
a series of diseases in humans and animals, including renal disease, cancer, reproductive 
defects, and endocrine disruption (4-5). Human exposure to cadmium through diet, 
smoking, pollution, and occupation is widespread (4,5). Cadmium released into the 
environment enters the food chain through its accumulation in plants, fish, shellfish, and 
other animals (4-7). Cadmium concentrations in plants usually range from 0.5 to 5 μM 
(6); however, in some plants, it can reach more than 100 μM (8). High levels of cadmium 
can be accumulated in soil due to pollution, abandoned mines, or geological features. The 
content of cadmium and acidity of soils determine cadmium levels in grains and 
vegetables produced from the land (4,7,8).  
 Cadmium has a high affinity for sulfhydryl (–SH) groups in proteins and 
glutathione, a major cellular reducing buffer, which results in inactivation of proteins and 
cellular oxidative stress (4,9,10). A recent report showed that cadmium markedly 
increases mutation rates by specifically inhibiting the DNA mismatch repair system (11). 
Cadmium exposure during pregnancy is associated with low birth weight and increased 
incidence of spontaneous abortion (4,7,11-14). Cadmium affects steroid synthesis 
pathways and secretion of progesterone, a hormone that plays critical roles in maintaining 
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pregnancy (12). Cadmium induces uterine hyperplasia, mammary gland development, 
and early onset of puberty in rat models (13,14). These estrogenic effects lead to 
infertility and cancer (14). Moreover, cadmium could exhibit synergistic estrogenic 
effects with other xenoestrogens, such as phytoestrogens in soybeans and vegetables (14).  
 Organisms have evolved systems for excretion and detoxification of non-
physiological metals and homeostatic acquisition of nutritional yet toxic metals. Metal 
transporters, cytosolic delivery molecules, and chelators have been identified in many 
organisms ranging from bacteria to humans (1,3,26-28). Given that cadmium is not a 
nutritional metal ion, organisms do not actively acquire cadmium. Rather, cadmium 
enters the body through non-specific mechanisms and/or transporters involved in the 
acquisition of essential metal ions. DMT1 (DCT1, Nramp2) iron transporter, zinc 
transporters, and calcium channels are all involved in cadmium absorption (15-19). 
Metallothionein (MT), a cysteine-rich low molecular weight metal-chelating peptide, and 
glutathione (GSH), a cysteine-containing tripeptide, sequester metal ions. In eukaryotes, 
this is considered the major mechanism for neutralizing toxic metals, including cadmium 
(20-23). Ace1 is a transcription factor inducing expression of copper defense genes in S. 
cerevisiae, including CUP1 and CRS5 encoding metal chelators, and SOD1 encoding a 
superoxide dismutase (24). Ycf1, a vacuolar membrane ATP-binding cassette (ABC) 
transporter, sequesters glutathione-conjugated cadmium and other metals into the vacuole 
(25). Thus, Δace1 and Δycf1 strains are sensitive to copper and cadmium, respectively. 
Phytochelatin, a GSH polymer synthesized in plants and fission yeast, also chelates heavy 
metals (21). Several heavy metal efflux pumps, including P1B-type ATPases, ABC 
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transporters, and cation diffusion facilitators play roles for extruding toxic heavy metals 
(3,26-28). These metal-transporters play vital roles for uptake, compartmentalization, and 
extrusion of nutritional and non-physiological heavy metals. In bacterial cells, P1B-type 
ATPases are vital for extrusion of metals, including cadmium, copper, and lead (26, 27). 
However, the cadmium efflux systems in eukaryotes remain uncharacterized.  
 Consistent to the fact that cellular defense systems respond to metal levels, 
several modes of regulation control expression, subcellular localization, and activities of 
P1B-type ATPases. Transcriptional control appears to be a major regulatory mechanism in 
bacteria and plants (26-28). In mammals copper controls subcellular trafficking of 
copper-transporting P1B-type ATPases. In a low copper medium, ATP7a and ATP7b are 
localized in the trans-Golgi network where they transport copper for its incorporation 
into secretory proteins (3,29). When copper levels are elevated, ATP7a is mobilized to 
the plasma membrane in a reversible manner (3,29). The biological significance of this 
molecular event is that ATP7a participates in copper uptake at the intestine and protects 
cells from copper toxicity. Excess copper mobilizes ATP7b from the trans-Golgi network 
to cytoplasmic vesicle-like compartments in the liver (3,29), which appears to be an 
important mechanism for excretion of excess copper into bile to maintain systemic 
copper homeostasis.  
 In a previous study, we demonstrated that Pca1, a predicted P1B-type metal-
transporting ATPase, is critical for cadmium defense in yeast S. cerevisiae (30). Pca1 is 
rapidly up-regulated in response to cadmium without any change in its transcript levels 
(30), which suggests a new mode of substrate-mediated regulation for this family of 
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proteins. To elucidate the mechanisms underlying the expressional control of Pca1 in 
response to cadmium, we have characterized the pathways for turnover of Pca1 and 
identified a metal-sensing cis-acting element that controls turnover of Pca1. Our data 
demonstrate that a degradation signal within the cysteine-rich N-terminus rapidly targets 
Pca1 for ubiquitination and degradation by the proteasome. This occurs before Pca1 
reaches the plasma membrane where it extrudes cadmium. However, direct cadmium 
sensing by the degradation signal prevents turnover, which leads to enhanced expression 
of Pca1. Cells have likely evolved this mode of regulation for a rapid and specific 
response against cadmium. Together, we have identified a new metal binding domain and 
revealed a unique mode of regulation for a P1B-type ATPase by its own substrate. 
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3.3. Experimental Procedures 
 3.3.1. Yeast Strains, Media, and Growth Conditions. A BY4741 haploid S. 
cerevisiae strain (MATa his3Δ1, leu2Δ0, met15Δ0, ura3Δ0) and null mutants, including 
ace1::KanMX6, ycf1:: KanMX6, pep4:: KanMX6, vps4::KanMX6 and pdr5:: KanMX6 
strains, were purchased from OpenBiosystems. Gene deletion in each strain was 
confirmed by PCR using gene specific primer sets. We received end4-1 (31), npi1 (32), 
and pre1-1pre2-1 (33) strains from Drs. Caroline Philpott, (National Institute of Health), 
Bruno André, (Universite Libré de Bruxelles), and Dieter Wolf (Universität Stuttgart), 
respectively. Yeast cells were cultured with synthetic complete (SC) media (2% dextrose, 
0.2% amino acid mixture, and 0.67% yeast nitrogen base) lacking specific amino acids 
for plasmid selection. If no temperature is specified, cells were cultured at 30 oC. For 
phenotypical analysis on solid media (1.5% agar), 5 μl of yeast cells (OD600 1.0) were 
spotted on selective media supplemented with the indicated concentrations of cadmium 
(CdCl2) or copper (CuCl2) and incubated at 30 °C for 2 days before photography. 
Cycloheximide chases were performed by the addition of 100 ug/mL cycloheximide to 
logarithmically growing cultures prior to collection into equal volumes of ice-cold kill 
buffer (phosphate buffered saline (PBS) containing 15 mM NaN3) at the indicated time 
points. For proteasome inhibition, a Δpdr5 strain that blocks proteasome inhibitor efflux 
(34), was cultured 5 hrs in the presence of 40 µM MG132 (Calbiochem) in 0.1% dimethyl 
sulfoxide (Sigma). 
 3.3.2. Plasmid Construction and Manipulation. If no expression vector is 
specified, single copy yeast vectors (p416-GPD) (35) were used for glyceradehyde-3-
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phosphate dehydrogenase (GPD) gene promoter-driven constitutive expression of Pca1, 
N-terminal truncated Pca1, CaCRP, Pca1-CaCRP fusion, N-terminal 250-350 peptide, 
Fet3 iron oxidase, CL1 degradation signal peptide, and Gap1 general amino acid 
permease. For the green fluorescent protein (GFP) or hemagglutinin (HA) epitope fusion, 
NotI flanked GFP or three tandem HA epitopes were inserted into the NotI site which was 
artificially generated after ATG translation start codon by PCR. Expression plasmids of 
CL1 artificial degradation signal fused with GFP were constructed as described (36,45). 
Site-directed mutagenesis was conducted by the primer overlap extension method (37). 
We sequenced all constructs to confirm correct sequence and in frame fusion. Common 
molecular biology techniques, including plasmid amplification using Escherichia coli, 
and purification, followed previously established methods (38). Plasmid transformation 
into yeast was performed using the lithium acetate method (39).  
 3.3.3. Fluorescence Microscopy. Yeast cells were cultured in SC selective media 
at 30 °C with agitation until mid-log phase. When indicated, metals (CdCl2 or CuCl2) 
were added to the culture media prior to imaging. Cells were collected, re-suspended in 
PBS and imaged on a confocal microscope (Olympus FV500) as described (30). 
 3.3.4. Immunoblotting. Total protein extracts were prepared by breaking cells 
with glass beads in PBS containing protease inhibitor cocktail (Complete Mini) (Roche) 
and 1% triton X-100. Protein concentrations were measured using the BCA kit (Pierce) 
according to the manufacturer’s specifications. Lysates were denatured in SDS sample 
buffer containing dithiothreitol (DTT) (25 mM) for 15 min at 37 °C and resolved by 
SDS-PAGE and transferred to a nitrocellulose membrane. GFP fusion proteins were 
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detected by rabbit anti-GFP polyclonal antibodies (Santa Cruz Biotechnology INC) and 
secondary goat anti-rabbit IgG antibodies conjugated to horseradish peroxidase (HRP) 
(Santa Cruz Biotechnology INC). HA-tagged proteins were probed with rabbit anti-HA 
polyclonal antibodies (Rockland) and secondary goat anti-rabbit IgG antibodies 
conjugated to HRP (Santa Cruz Biotechnology INC). Loading control, 3-
phosphoglycerate kinase (PGK), was detected with mouse monoclonal anti-PGK 
antibodies (Molecular Probes) and secondary sheep anti-mouse IgG antibodies 
conjugated to HRP (Amersham). Signals were captured on film (Midwest Scientific) by 
chemiluminescence (SuperSignal West Pico) (Pierce). 
 3.3.5. Detection of Ubiquitination. Cells were broken by glass beads in PBS 
containing protease inhibitors (Complete Mini) (Roche), 5 mM N-ethylmaleimide, 1 mM 
phenyl-methylsulfonyl fluoride, and 1% Triton X100. HA-tagged proteins were 
immunoprecipitated with an HA-Tag IP/Co-IP kit (Pierce) according to manufacturer 
specifications. Proteins were eluted by incubation of immobilized anti-HA agarose beads 
in 2XSDS sample buffer at 37 °C for 15 min and reduced in the presence of 0.1 M DTT 
for an additional 15 min at 37 °C. Ubiquitin-conjugated proteins were detected by 
immunoblotting using mouse monoclonal antibodies against ubiquitin (Covance).  
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3.4. Results 
 3.4.1. Cadmium Rapidly Induces Pca1 Expression by Increasing Stability. A 
unique feature of Pca1 is a cytosolic cysteine-rich N-terminal extension of nearly 400 
residues (Fig. 3.1A). To investigate the mechanism underlying the post-transcriptional 
regulation and role of the N-terminal extension in turnover of Pca1, we have constructed 
expression plasmids of full length Pca1 and Pca1 with truncation of the first 392 amino 
acids. A GFP or triple HA epitope was fused at the N-terminus. All Pca1 constructs were 
functional in conferring cadmium resistance  (Fig. 3.1B). Western blot analysis of Pca1 
showed that Pca1 is a short-lived protein (t1/2 < 5min) (Fig. 3.1C). However, up-
regulation of Pca1 is clearly visible 5 min after addition of cadmium to culture media 
(Fig. 3.1D), indicating a rapid cellular response to cadmium. Pca1 tagged with the GFP or 
c-myc epitope at the N or C-terminus, respectively, also showed similar regulation by 
cadmium (data not shown), suggesting that cadmium’s effect on Pca1 expression is 
independent of epitope or its location. This expression control by cadmium can be 
explained by enhanced translation or stability of Pca1 protein. To decipher these two 
possibilities, Pca1 turnover rate was examined by cycloheximide chases in the absence or 
presence of cadmium in culture media. Indeed, stability of Pca1 is dramatically increased 
in the presence of cadmium (Fig. 3.1E). These data suggest that the induction of Pca1 
occurs through cadmium’s ability to prevent the rapid turnover of Pca1.   
3.4.2. Pca1 Is Not Stabilized in a Strain Defective in Endocytosis. In yeast, 
several plasma membrane proteins are internalized into endocytic vesicles that enter the 
early  
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Figure 3.1. Cadmium rapidly enhances Pca1 expression by increasing stability. A, 
Schematic depiction of the Pca1 P1B-type ATPase. Gray and black rectangles represent 
the N-terminal cysteine-rich cytosolic domain encompassing the first 392 amino acids 
and eight predicted transmembrane domains, respectively. B, Cadmium resistance in 
cells expressing Pca1 alleles. Pca1, N-terminal GFP-fused Pca1 (GFP-Pca1), three 
tandem HA epitope-tagged Pca1 (HA-Pca1), and Pca1 deleted of the N-terminal 
cysteine-rich domain (Pca1Δ392) with or without N-terminal GFP fusion were 
expressed in a BY4741 yeast strain in which endogenous Pca1 is non-functional (30). 
Cells (5 μl, OD600 1.0) were spotted on SC solid media containing the indicated 
concentration of CdCl2, and then cell growth was assessed after two days. C, D, and E, 
HA-Pca1 expression was detected by Western blotting using anti-HA antibodies. The 
same blot was probed for PGK to determine equal loading. C, Cycloheximide chase of 
yeast cells expressing HA-Pca1. Exponentially growing cells were co-cultured with 
cycloheximide (100 µg/mL) and then collected at the indicated time points for Western 
blot analysis. D, Rapid up-regulation of Pca1 in response to cadmium. Cadmium (50 
μM CdCl2) was added to exponentially growing yeast cultures, and then cells were 
collected into ice-cold kill buffer (15 mM NaN3 PBS) at the indicated time points. E, 
Cadmium-induced stabilization of Pca1 determined by cycloheximide chase. Yeast 
cells pre-cultured for 15 min without (NT) or with cadmium (20 μM CdCl2) were 
collected at the indicated time points. Cycloheximide (100 µg/mL) was added to the 
culture media after collection of time zero. Total protein extracts were subject to 
Western blot analysis.  
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endosome where they can be recycled back to the surface or are delivered to the vacuole 
for degradation (40,41).  We considered that Pca1 might be transiently localized at the 
cell surface before being rapidly internalized and degraded.  In this pattern of trafficking, 
cadmium sensing would shift the distribution of Pca1 to the cell surface for cadmium 
efflux. If the internalization step were to be blocked then Pca1 would be expected to 
accumulate at the plasma membrane in the absence of cadmium. To test this possibility, 
we investigated the subcellular localization of Pca1 fused with GFP (Fig. 3.1B) in a strain 
harboring a temperature-sensitive allele of END4. This strain exhibits conditional defects 
in both fluid phase and receptor-mediated endocytosis at the restrictive temperature (31). 
Confocal microscopy revealed that GFP-Pca1 expressed in the end4-1 mutant at the 
restrictive temperature did not accumulate at the plasma membrane (data not shown) and 
remained unstable as demonstrated by cycloheximide chase (Fig. 3.2A). The defect in 
endocytosis was confirmed by inhibition of internalization of the membrane impermeable 
dye, Lucifer Yellow CH (31) in the end4-1 strain at the restrictive temperature (data not 
shown). These results suggest that Pca1 turnover in the absence of cadmium occurs either 
at the plasma membrane or before sorting to the plasma membrane.  
3.4.3. Pca1 Degradation Is Dependent on the Proteasome But Not Vacuolar 
Proteases. Plasma membrane proteins can be directly sorted to the vacuole for 
degradation. For instance the Gap1 amino acid permease is directly targeted to the 
vacuole when preferred nitrogen sources are available (42). Perhaps, in an analogous 
manner Pca1 may sense cadmium before trafficking to the plasma membrane or is 
otherwise degraded by the vacuole. To test this, we examined localization and turnover 
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rate of Pca1 in a Δpep4 strain that is deficient in vacuolar protease activity (43). GFP-
Pca1 did not accumulate in the vacuole of the Δpep4 strain, which was distinct from 
Fet3-GFP, a cell surface iron oxidase, previously shown to undergo vacuolar degradation 
(44) (data not shown). A cycloheximide chase confirmed that Pca1 undergoes 
degradation at a similar rate in the Δpep4 background compared to an isogenic wild-type 
strain (Fig. 3.2B), suggesting no significant role for vacuolar proteases in degradation of 
Pca1.  The dependence of Pca1 degradation through the vacuolar/endosomal pathway 
was further examined in a Δvps4 null mutant, which is defective in both anterograde (late 
endosome-to-vacuole) and retrograde (late endosome-to-Golgi) trafficking. Resident 
proteins of the late endosome are typically trapped in pre-vacuolar 
compartments/multivesicular bodies in vps4 mutants. As shown in figure 3.2C, GFP-Pca1 
does not accumulate in such compartments, unlike Fet4-GFP. We conclude that Pca1 
degradation is not dependent on the vacuolar degradation pathway.  
 Given that Pca1 turnover is not dependent on vacuolar proteases, we questioned 
whether the rapid degradation of Pca1 was dependent upon the proteasome. Indeed, 
treatment of cells with the protease inhibitor MG132 led to a significant increase in Pca1 
expression compared to vehicle-treated controls (Fig. 3.2D). This experiment was 
performed in a Δpdr5 strain, previously shown to limit the efflux of protease inhibitors 
(34). We also examined the steady state expression of Pca1 in a pre1-1 pre2-1 double 
mutant, which is defective in proteasomal activity (33). Consistently, Pca1 is stabilized in 
this strain although to a much lesser extent, which is likely due to some remaining 
proteolytic activities in the pre1-1pre2-1 strain that participates in Pca1 degradation (Fig. 
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3.2D).  Consistent to the fact that ubiquitination is a pre-requisite for proteasomal 
targeting, ubiquitination of Pca1 was readily detectible (absence of ubiquitin ladder (Fig. 
3.2F).  However, it is diminished to non-detectable levels after cells are exposed to 
cadmium (Fig. 3.2F). This observation hints toward a mechanistic explanation for 
cadmium’s role in preventing the degradation of its own exporter. Rsp5 is an E3 
ubiquitin-protein ligase that is known to be involved in regulation of several plasma 
membrane proteins, such as metal dependent down regulation of the Znt1 zinc transporter 
and Smf1 manganese transporter (40). However, an Rsp5-deficient strain did not stabilize 
Pca1 (data not shown), suggesting no role for this ubiquitin-protein ligase in Pca1 
turnover.  
 To exclude the possibility that stabilization of Pca1 by cadmium may reflect toxic 
effects of cadmium on the cellular systems for ubiquitination and proteasomal 
degradation, we tested the effects of cadmium on the expression of GFP-CL1 that has 
been utilized as a reporter for determining the activities of the ubiquitination-proteasome 
pathway (45). As shown in Fig. 3.2G, cadmium exposure at the same concentrations that 
markedly stabilize Pca1 (Fig. 3.1E) had no significant influence on the expression levels 
of GFP-CL1. Thus, cadmium’s inhibition of proteasomal degradation of Pca1 is specific.  
Our previous data also showed that Pca1 protein expression is enhanced when yeast cells 
are exposed to cadmium as low as 1 μM concentrations (30) which are similar to those 
found in plants where natural yeast cells grow (6).  
 3.4.4. The Cysteine-rich Cytosolic Extension Contains a Degradation Signal. 
We postulated that Pca1’s cysteine-rich N-terminal extension might contain a metal- 
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responding degradation signal. Indeed, while full-length Pca1 is hardly detectable in the  
 
 
Figure 3.2. Proteasome-dependent degradation of Pca1 and prevention of 
ubiquitination by cadmium. A, Cycloheximide chase and Western blotting of HA-
Pca1 expressed in end4-1 strain and isogenic parental strain (WT). Cells were 
cultured at 37 oC to block endocytosis and collected at the indicated time points for 
Western blot analysis. B, Cycloheximide chase of HA-Pca1 expressed in Δpep4 strain 
and isogenic parental (WT) strain. C, Confocal imaging of GFP-Pca1 or Fet4-GFP 
expressed in Δvps4 or isogenic parental strain. D, Empty vector or HA-Pca1 was 
expressed in Δpdr5 cells in which proteasome inhibitor efflux is reduced (34). Cells 
were cultured in the presence (+) or absence (-) of proteasome inhibitor MG132 (40 
µM, 5 hrs). Total protein extracts were subject to Western blot analysis using anti-HA 
antibodies. E, HA-Pca1 was expressed in a temperature-sensitive pre1-1pre2-1 
proteasome defective mutant or isogenic parental strain (WT) at restrictive 
temperature (37oC) for two hours. Relative expression of HA-Pca1 was detected by 
anti-HA immunoblotting. F, Cadmium inhibits Pca1 ubiquitination. Cells expressing 
HA-Pca1 were cultured with (+) or without (-) cadmium (50 μM CdCl2, 2 hrs). HA-
Pca1 in total protein extracts was immunoprecipitated with beads conjugated with 
anti-HA antibodies. HA-Pca1 and ubiquitin-attached HA-Pca1 were detected by 
immunoblotting using anti-ubiquitin (Ub) and anti-HA antibodies. Arrow indicates 
the expected migration of non-ubiquitinated HA-Pca1. G, Cadmium does not stabilize 
a model substrate of the ubiquitination-proteasome degradation pathway. Expression 
levels of GFP-CL1 were detected in cells pre-cultured for 1 hr without (NT) or with 
cadmium (50 μM CdCl2). Cycloheximide (100µg/mL) was added to the culture media 
after collection of time zero. Total protein extracts prepared from cells collected at the 
indicated time points were subject to Western blot analysis using anti-GFP antibodies.  
PGK was probed to determine equal loading. 
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absence of copper or cadmium, deletion of this domain (Pca1Δ392) resulted in 
constitutive expression at the cell surface even in the absence of cadmium (Fig. 3.3A and 
3.3B). These data strongly suggest that Pca1 turnover occurs via this domain. Consistent 
with the idea that Pca1 ubiquitination is dependent on a degradation signal within the N-
terminal domain, ubiquitination was not detected in Pca1Δ392 (Fig. 3.3C). While the 
Pca1(1-392) domain is necessary for Pca1 turnover, co-expression of this domain with 
Pca1Δ392 separately did not lead to enhanced turnover of Pca1Δ392 (data not shown). 
This suggests that in order to serve as a degradation signal for Pca1 this domain should be 
associated with the entire protein. 
 To determine whether the N-terminal regulatory domain is sufficient for 
controlling the expression of another plasma membrane transporter, we fused the peptide 
comprising amino acid residues 1 to 392 of Pca1 to the N-terminus of a copper-
transporting P1B-type ATPase (CaCRP) identified from C. albicans (46,47) and then 
expressed in S. cerevisiae. The Pca1(1-392)-CaCRP fusion was fully functional in 
conferring copper tolerance to yeast cells indicating correct folding and trafficking (Fig. 
3.4A). Confocal microscopy (Fig. 3.4B) and Western blot analysis (Fig. 3.4C) 
demonstrated that residues 1 to 392 in Pca1 control CaCRP expression specifically in a 
cadmium and copper dependent manner. Hence, this domain functions as an autonomous 
degradation signal that can be masked when cells are growing in media supplemented 
with cadmium or copper. 
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Figure 3.3. The cysteine-rich N-terminus of Pca1 contains a degradation signal. 
A, Metal-dependent expression of GFP-Pca1 or GFP-Pca1Δ392. Cells expressing 
GFP-Pca1 or GFP-Pca1Δ392 were cultured in the absence (NT) or presence of metal 
ions (50 μM CuCl2, 50 μM CdCl2, or 15 mM ZnCl2 for 1 hr). GFP fluorescence in 
cells was visualized by confocal microscopy. Copper sensitive Δace1 strain (24) was 
used for these experiments presented in both A and B. B, Western blotting of GFP-
Pca1 and GFP-Pca1Δ392 in cells cultured with (+) or without (-) cadmium (50 μM 
CdCl2 for 2 hrs) using anti-GFP antibodies. Asterisk indicates non-specific bands. Top 
arrow indicates full-length GFP-Pca1 and bottom arrow indicates GFP-Pca1Δ392. C, 
Ubiquitination of Pca1 is dependent on the N-terminal domain. HA-Pca1 and HA-
Pca1Δ392 were immunoprecipitated and then detected by Western blotting using anti-
ubiquitin (Ub) and anti-HA antibodies. 
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Figure 3.4. The N-terminal cytosolic extension of Pca1 is an auto-regulatory 
domain that can be masked by cadmium and copper. A, Yeast cells expressing 
GFP-tagged wild-type CaCRP or CaCRP fused with the first 392 amino acids of the 
N-terminus of Pca1 (Pca1(1-392)) were spotted on solid media containing toxic 
copper (CuCl2, 0.1 mM). B, Expression of GFP-CaCRP and GFP-Pca1(1-392)-
CaCRP in cells cultured with CuCl2 or CdCl2 (50 μM, 2 hrs) were determined by 
visualization of GFP fluorescence with confocal microscopy. C, Western blot 
analysis of cells cultured as described above (B) using anti-GFP antibodies. A 
copper sensitive Δace1 strain (24) was used for these experiments. 
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We aligned this domain with characterized P1B-type ATPases and other proteins. 
However, the Pca1 N-terminal domain does not possess any significant sequence 
similarity to known proteins. Therefore, we employed a mapping strategy to define a 
signal sequence of metal-dependent degradation. Serial deletions of the N-terminus and 
fusion of various Pca1 N-terminal fragments to CaCRP were made (Fig. 3.5A) and then 
expressed in yeast cells. Characterization of expression levels and metal-dependent 
stabilization using confocal microscopy revealed that a region encompassing residues 250 
to 350 (Pca1(250-350)) is necessary and sufficient for both rapid turnover and cadmium 
or copper- dependent stabilization (Fig. 3.5A and 3.5B). Since the Pca1(250-350) 
degradation signal likely interacts with cellular factor(s) necessary for Pca1 degradation, 
we hypothesized that excess expression of this domain would compete for degradation of 
full-length Pca1. Indeed, co-expression of the Pca1(250-350) peptide with Pca1 leads to 
enhanced expression of Pca1 (Fig. 3.5C). Collectively, these data indicate that this 
Pca1(250-350) contains a degradation signal that can be masked by metal sensing.  
3.4.5. Cysteine Residues within the Pca1 Regulatory Domain Are Required 
for Metal Sensing. This 250-350 amino acid peptide contains seven cysteine residues 
(Fig. 3.6A). Given that cysteine is a known metal ligand, we predicted metal ion binding 
to this domain. A Pca1(250-350) peptide tagged with three tandem copies of HA epitope 
(HA-Pca1(250-350)) was expressed in Δace1 or Δycf1 strains that are sensitive to copper 
or cadmium, respectively (24,25). We hypothesized that this peptide would bind and 
sequester metal ions like metallothionein (20), which would confer resistance to copper 
and cadmium. Growth assays on media containing copper or cadmium at toxic levels  
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Figure 3.5. The N-terminal domain encompassing amino acids 250 to 350 is 
necessary and sufficient for the control of Pca1 and CaCRP expression in a 
metal-dependent manner. A, Pca1 with or without N-terminal truncations and 
Pca1 N-terminal fragments fused with CaCRP were expressed in yeast. A GFP 
was tagged in frame at the N-terminus of these expression constructs for 
visualization. Steady state GFP fluorescence in cells growing exponentially was 
scored as weak (-) or strong (+) by confocal microscopy. Cadmium (50 μM 
CdCl2 for 2 hrs) dependent enhancement (+) of GFP fluorescence was 
determined. B, Confocal microscopy of GFP-Pca1(250-350)-CaCRP fusion in 
cells cultured in the absence (NT) or presence of metals (50 μM CuCl2 or CdCl2 
for 2 hrs). C, Determination of HA-Pca1 expression levels in cells with (+) or 
without (-) co-expression of the Pca1(250-350) peptide. HA-Pca1 was detected 
by immunoblotting with anti-HA antibodies. PGK in the same blot was probed 
as a loading control. A copper sensitive Δace1 strain (24) was used for these 
experiments. 
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showed that cells expressing HA-Pca1(250-350) displayed cadmium and copper 
resistance compared with empty vector transformed cells (Fig. 3.6B). However, this 
peptide did not confer zinc tolerance in a zinc-sensitive strain (data not shown). These 
data are in accordance with that both cadmium and copper, but not zinc, stabilized Pca1 
(Fig. 3.3A) and CaCRP fused with this regulatory domain (data not shown). The same 
peptide in which all cysteine residues are substituted to alanine (ΔCys), did not confer 
metal resistance (Fig. 3.6B), supporting roles for cysteine residues in metal binding. To 
ensure equal or greater levels relative to the wild-type peptide (Fig. 3.6D), we expressed 
HA-Pca1(250-350)ΔCys peptide using a high-copy plasmid. 
 We next examined which cysteine residues within this domain play roles for 
conferring resistance to cadmium and/or copper. Site-directed mutation of the CxC motif 
(C298A, C300A) abolished copper resistance but not cadmium resistance (Fig. 3.6C). 
Conversely, mutation of the CC motif (C311A, C312A) abolished cadmium resistance 
yet retained the ability to confer copper resistance (Fig. 3.6C). These data support distinct 
roles for these cysteine residues in copper or cadmium coordination.  
 We predicted that cysteine mutations would compromise metal-dependent 
masking of the degradation signal. Indeed, cadmium or copper could not stabilize CaCRP 
fused with HA epitope-tagged Pca1(250-350) where all seven cysteine residues were 
substituted to alanine (ΔCys) (Fig. 3.6E upper panel, fifth and sixth lanes). However, 
steady state expression levels without metal addition to culture media (NT) were not 
significantly different between control (WT) and cysteine mutant (ΔCys) (Fig. 3.6E upper 
panel, first lane versus fourth lane) suggesting that cysteine residues are specifically 
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necessary for cadmium or copper-induced stabilization but not turnover. Collectively, 
these data suggest that cysteine-based metal sensing within a cis-acting degradation 
signal serves as a molecular switch for rapid up-regulation of Pca1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Cysteine residues within the regulatory domain of Pca1 are required 
for metal sensing. A, Sequence of a metal-responsive degradation signal 
encompassing amino acids 250 to 350 in the N-terminus of Pca1. Seven cysteine (C) 
residues are in boldface. C298, C300, C311, and C312 are underlined. B, Empty vector 
(V), a single-copy expression vector of N-terminal triple HA-tagged Pca1(250-350) 
(HA-Pca1(250-350), WT), and a multi-copy expression vector of HA-Pca1(250-350) 
with substitution of all seven cysteine residues to alanine (ΔCys) were transformed into 
copper sensitive Δace1 (24) and cadmium sensitive Δycf1 (25) strains. Cells growing 
exponentially were spotted on SC media without (NT) or with supplementation of toxic 
copper or cadmium (50 μM CuCl2 or CdCl2). Cell growth was assayed after two days. 
C, Empty vector (V) and an expression vector of HA-Pca1(250-350) possessing 
specific cysteine mutations as indicated were transformed into cells. Cell growth was 
determined as described above (B). D, Western blotting of the HA-Pca1(250-350) 
peptides in total protein extracts of cells described above (B) with anti-HA antibodies. 
PGK was detected to determine equal loading. E, CaCRP fused with HA-Pca1(250-
350) at the N-terminus without (WT) or with site-directed mutagenesis of all seven 
cysteine residues to alanine (ΔCys) were expressed in a Δace1 strain. Total protein 
extracts of cells cultured without (NT) or with copper or cadmium (20 μM CuCl2 or 
CdCl2 for 1 hr) were subject to Western blot analysis using anti-HA and anti-PGK 
antibodies. 
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3.5. Discussion 
 Our data reveal a new mode of expressional control of a metal-transporting P1B-
type ATPase. In the absence of cadmium, Pca1 is rapidly targeted for degradation at the 
proteasome via an N-terminal degradation signal. However, cadmium sensing allows 
Pca1 to circumvent degradation, which is likely attributed to conformational changes 
within the degradation signal induced by metal binding. Hence, cells are able to rapidly 
express Pca1 at the cell surface only when Pca1 is required for cadmium efflux.  
 Since cadmium is extremely toxic and cadmium levels in the environment 
fluctuate, transcriptional or translational regulation of a cadmium detoxification system 
may not be fast enough for cell protection. The constant synthesis of Pca1 would be an 
obvious advantage in coping with this problem. The underlying reason for rapid 
degradation of Pca1 could be explained by the fact that Pca1 expression is not necessary 
when cells are growing without cadmium stress. However, other factors may be 
important for keeping Pca1 levels at a minimum. For example, Pca1 could play another 
role other than cadmium efflux (e.g., efflux of nutritional metals), which would be 
deleterious in the absence of cadmium. Indeed, it was shown that cells over-expressing 
Pca1 grow slowly (48). If Pca1 transports nutritional metal ions due to broad substrate 
specificity, as shown for several other metal-transporting P-type ATPases (26-28), 
expression of Pca1 only when cadmium is in excess could prevent loss of essential metals 
that are limiting for growth. While our previous data showed that Pca1 does not change 
cellular accumulation of zinc, manganese, cobalt, or iron (30), Pca1 may transport these 
or other metal ions under specific growth conditions. Secondly, it is not known what 
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form(s) of cadmium and other metals are substrates of P1B-type ATPases. Ycf1, a 
vacuolar cadmium ABC transporter in yeast, transports both glutathione-conjugated 
cadmium and glutathione itself (25,49). A recent report showed that cysteine dramatically 
increases the activities of CopA, ZntA and HMA2 P1B-type ATPases (50). Pca1 may 
extrude cysteine, glutathione, or other ions such as sulfur with or without conjugation of 
cadmium. If so, constitutive extrusion of these cellular factors would be deleterious, since 
they are critical for redox homeostasis and metabolism (51,52). Alternatively, cysteine or 
other cytosolic molecules may activate Pca1 as shown for ZntA and HMA2 (50), 
resulting in constitutive ATP hydrolysis in the absence of cadmium. 
 Internalization followed by degradation at the vacuole is a major pathway for 
turnover of plasma membrane proteins. For example, Zrt1 zinc transporter, Fet3/Ftr1 iron 
transporter complex, and Smf1 manganese transporter are subject to this mode of 
posttranslational regulation (40,44,53,54). Given that these transporters play roles in 
metal ion uptake, they are down regulated when cells are exposed to excess metal ions. 
Substrate-dependent ubiquitination of membrane transporters is often a signal that 
triggers turnover of these transporters (40). However, Pca1 regulation by cadmium is 
unique when compared with these other metal ion transporters in that it is rapidly up-
regulated by cadmium-mediated rescuing from degradation. Moreover, degradation of 
Pca1 occurs at the proteasome in an endocytosis-independent manner. It is interesting to 
note that cellular trafficking of Arn1, a transporter of an iron-siderophore complex, is 
regulated by its substrate at several steps. Substrate sensing triggers plasma membrane 
sorting of Arn1, and its cycling between the plasma membrane and endosomes is induced 
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by substrate binding at the cell surface (55,56). Pca1 sorting to the cell surface versus 
degradation at the proteasome may be controlled by a similar mechanism as characterized 
for Arn1. We are currently pursuing the identification of molecular factors that are 
involved in Pca1 turnover and the subcellular compartments where cells determine the 
fate of Pca1.       
 Most P1B-type ATPases possess N-terminal metal binding domains (MBDs) that 
are thought to play roles in catalysis and/or regulation. The conserved MBD (~70 amino 
acids, βαββαβ fold) contains a GMXCXXC sequence in which two cysteine residues 
coordinate a metal ion (3,29). While this domain is conserved in many P1B-type ATPases, 
the numbers of it vary, ranging from one to six. The N-terminus of Pca1 contains only 
one conserved MBD in which two cysteine residues are essential for function (30). 
Human copper transporting ATPases possess six MBDs at the N-terminus. The Atx1 
metallochaperone delivers copper through direct docking to MDBs with different 
preferences among them (57-59), suggesting distinct functions of these domains. The 
structure and metal coordination of MBDs are relatively well characterized; however, the 
roles for these domains in ATPase function are not yet clear. Copper binding was initially 
proposed as a substrate recognition step followed by transfer of metal to the translocation 
pore. However, site-directed mutagenesis and deletion of MBDs suggest a regulatory 
role. For example, the 5th or 6th MDB of human ATP7a is necessary and sufficient for 
copper-induced redistribution (60). An inhibitory role of the N-terminus of a copper 
transporting ATPase has been proposed as well (61). Interestingly, a recent report (62) 
suggested the presence of either additional regulatory copper-binding site(s) within the 
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protein or another unknown mechanism for copper sensing. Collectively, while 
significant progress in the characterization of conserved MBDs in N-terminus of P1B-type 
ATPases has been made, the functional roles of these domains remain elusive.  
 We have identified a distinct MBD in the N-terminus of Pca1 that is necessary for 
extremely efficient control of Pca1 expression in response to cadmium. Several atypical 
MBDs have been identified in other P1B-type ATPases as well. The core sequence of N-
terminal MBD’s of A. thaliana HMA2-4 is substituted by a degenerate sequence, 
GICC(T/S)SE (63). HMA2 and HMA4 zinc ATPases possess C-terminal MBDs (several 
di-cysteine pairs and an eleven histidine stretch) that regulate enzyme activities (63,64). 
A CHHC predicted metal binding sequence was identified at the C-terminus of the CopA 
copper ATPase in Archaeoglobus fulgidus (65). The histidine-rich N-terminal metal 
binding domain of the CopB copper ATPase in A. fulgidus appears to have a regulatory 
role affecting metal transport rates by controlling metal release (66). In addition to heavy 
metal-transporting P1B-type ATPases, it was also shown that Ca2+-transporting P-type 
ATPases carry inhibitory domains (67). Cytosolic regulators and phosphorylation of C-
terminal residues control activities of H+-transporting ATPases in plants (68). Hence, 
auto-regulatory mechanisms may be widespread in P-type ATPases.  
 We propose that direct metal binding to the Pca1(250-350) domain induces 
conformational changes that would mask a signal recognized by the protein degradation 
machinery. Expression of Pca1(250-350) itself confers both cadmium and copper  
tolerance, which supports the conclusion that this domain directly binds metals. 
Substitution of cysteine residues within this domain abolished metal resistance suggesting 
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a role for cysteines in metal coordination. Site-directed mutation of cysteine residues 
suggests that binding site(s) of cadmium and copper do not overlap directly. Given that 
Pca1 does not transport copper (30), the physiological significance of the stabilization of 
Pca1 by copper is not obvious at this moment. It is necessary to point out that in a 
copper-sensitive Δace1 strain Pca1 stabilization by copper is observed at similar 
concentrations to that of cadmium; however, in wild-type cells relatively high copper 
concentration (~2 mM) is necessary for Pca1 stabilization (data not shown). CUP1 and 
CRS5-encoded metal chelators that are up-regulated by Ace1 likely have higher affinity 
to copper than the N-terminus of Pca1.  
 Fusion of the Pca1(250-350) domain with a stable protein leads to a rapid 
turnover and metal-dependent stabilization, demonstrating a role as a autonomous and 
metal-responsive degradation signal. However, this domain does not carry significant 
sequence identity with characterized degradation signals or known proteins. Given that 
Pca1(250-350) is located in the middle of the N-terminus, the N-end rule pathway of 
protein degradation is unlikely involved in Pca1 degradation (69). Pro, Glu, Ser, and Thr 
amino acid enriched sequence (PEST sequence) is a proteolytic signal (70). However, 
Pca1 250-350 is not predicted to contain a PEST signal (https;//embl.bcc.univie.ac.at/). It 
has been proposed that exposure of hydrophobic residues could recruit molecular 
chaperones, which results in re-folding to a functional protein or targeting for 
degradation. Structural characterization of this domain in apo and cadmium-bound forms 
would reveal what characteristics lead to degradation of Pca1 and how metal binding 
masks this degradation signal. We are currently pursuing characterizations of structure 
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and metal binding of this domain in detail; however, purification of ample quantities of 
the Pca1(250-350) peptide has been a technical challenge (Adle and Lee, unpublished 
data).  
 It is interesting to note that the N-terminus of a human copper ATPase interacts 
with several proteins, although the physiological significance of these interactions 
remains to be elucidated. For example, MURR1/COMMD1 binds with the N-terminus of 
ATP7b, which decreases stability of newly synthesized ATP7b (71). A hepatocytic 
isoform of PLZF (promyelocytic leukemia zinc finger) protein interacts with the C-
terminus of ATP7b, which positively regulates ERK signal transduction (72). 
Glutaredoxin interacts with the N-terminus of ATP7a and ATP7b (76), and the dynactin 
subunit p62 interacts with the N-terminus of ATP7b (73). These protein-protein 
interactions may play critical roles for the function, regulation of catalytic activities, 
and/or subcellular trafficking of ATP7b and possibly other P1B-type ATPases. The 
regulatory domain identified at the N-terminus of Pca1 may interact with accessory 
protein(s) that target Pca1 to the ubiquitin-proteasome pathway.  
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Chapter 4 
 
Cadmium-mediated rescue from ER-associated degradation 
induces expression of its exporter 
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4.1. Abstract 
 Cadmium is a highly toxic environmental contaminant implicated in various 
disorders. A major mechanism for cadmium detoxification in yeast Saccharomyces 
cerevisiae relies on extrusion via Pca1, a P-type ATPase. While an N-terminal degron 
targets Pca1 for degradation before its secretion to the plasma membrane, cadmium in the 
growth media rapidly up regulates Pca1 by preventing its turnover. Here we show that the 
endoplasmic reticulum-associated degradation (ERAD) system, known for its role in 
protein quality control of secretory proteins, is unexpectedly responsible for the 
regulation of Pca1 expression by cadmium. Direct cadmium sensing at the ER leads to 
conformational changes of this degron, which suggests how recognition of Pca1 for 
ERAD is prevented. This regulated conversion of an ERAD substrate to a secretory 
competent state in response to a cellular need illustrates a novel mechanism for 
expressional control of a plasma membrane protein. Yeast has likely evolved this mode 
of regulation for a rapid response against cadmium toxicity at the expense of constant 
synthesis and degradation of Pca1. ERAD of a portion of secretory proteins might occur 
via signal-dependent regulatory mechanisms as demonstrated for Pca1. 
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4.2. Introduction   
Metal ions are highly toxic, although several metals such as iron, copper and zinc 
are essential micronutrients. Organisms possess delicate systems for detoxification and 
excretion of nonphysiological metals and homeostatic metabolism of nutritional yet toxic 
metals (1,2). Pca1 in S. cerevisiae is a multi-spanning transmembrane protein that 
belongs to the family of P1B-type ATPase heavy metal transporters widely distributed 
from bacteria to humans (3). Pca1 functions in the efflux of cadmium across the plasma 
membrane (4), an extremely toxic environmental pollutant that causes various human 
diseases, such as cancer, kidney disease and endocrine disruption (5).  
 We have previously demonstrated that Pca1 is a short-lived protein that is targeted 
for ubiquitination and proteasomal degradation before reaching the cell surface (6). 
However, in the presence of cadmium, Pca1 is rapidly up regulated due to the prevention 
of its degradation (6). An autonomous degron encompassing amino acid residues 250-350 
within the N-terminal cytosolic domain is necessary and sufficient for both degradation 
and metal sensing (6). Given that the cell surface expression of several plasma membrane 
proteins is regulated by ubiquitin-mediated endocytosis followed by vacuolar 
degradation, Pca1 turnover and cadmium-responsive degradation represents an 
interesting mode of expressional control in which subcellular trafficking and stability are 
determined by its substrate during secretion. 
 To uncover molecular factors involved in the expressional control of Pca1, we 
have devised a genetic screen to identify mutants that are defective in Pca1 degradation in 
the absence of cadmium. Unexpectedly, our data presented herein demonstrate that 
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components of the ER associated degradation (ERAD) system target Pca1 for 
proteasomal degradation.  
Secretory proteins in eukaryotes are inserted into the ER lumen or membrane 
where correct folding and maturation occurs. Numerous factors, such as molecular 
chaperones, glycosylation enzymes, and protein disulfide isomerases, are involved in this 
process. Genetic mutations and environmental stresses (e.g., heat, oxidative stress) 
enhance the probability of failure of protein folding and maturation. The unfolded protein 
response (UPR) pathway enhances the capability of protein folding when cells are 
challenged by these stresses (7). The ERAD system eliminates terminally misfolded or 
unassembled proteins, which is critical for the prevention of toxic accumulation of 
aberrant proteins (8, 9). Several mutant proteins, unassembled subunits of secretory 
proteins, and heterologously expressed proteins have all been identified as ERAD 
substrates (8, 9). However, Pca1 is a naturally expressed and functional protein and there 
is no evidence of multimer assembly for pca1. 
 Cadmium is extremely toxic and its levels fluctuate in the environment. Thus, 
transcriptional and/or translational control of defense factors may not be fast enough for 
cell protection. Our results suggest that yeast cells have evolved to harness the ERAD 
system for rapid up-regulation of Pca1 cell surface expression by direct sensing of 
intracellular cadmium at the ER.  
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4.3. Experimental Procedures 
4.3.1. Yeast strains, media and growth conditions. Yeast strains used in this 
study are listed in Table 4S1. Most strains are from the Saccharomyces Genome Deletion 
Project (10) which was purchased from Open Biosystems. Double knockouts were 
generated by PCR-based gene deletion using pFA6a-His3MX6 as a template for 
homologous recombination (11). Diagnostic PCR using gene-specific primer sets 
confirmed correct replacement of target genes by the His3MX6 cassette. Yeast cells were 
cultured in YPD or synthetic complete (SC) media as previously described (4). 
4.3.2. Construction of expression plasmids and transformation. A single copy 
yeast vector was used for glyceraldehyde-3-phosphate dehydrogenase (GPD) gene 
promoter-mediated constitutive expression unless specified (12). For the generation of 
expression plasmids of green fluorescent protein (GFP) or triple hemagglutinin (HA) 
epitope-fusion proteins, NotI restriction enzyme site-flanked GFP or three tandem HA 
epitopes were inserted into a NotI site artificially generated at the N or C-terminal end. A 
plasmid containing four tandem copies of the 22bp Unfolded Protein Response Element 
(UPRE) inserted upstream of a disabled CYC1 promoter lacZ gene fusion (13) was 
kindly provided by Dr. Peter Walter (University of California, School of Medicine, San 
Francisco, California). A Ste6* expression plasmid (14) was generously provided by Dr. 
Susan Michaelis (John Hopkins School of Medicine, Baltimore, Maryland). Site-directed 
mutagenesis was conducted by the primer overlap extension method (15). Plasmids were 
transformed into yeast using the lithium acetate procedure (16). Yeast cells were grown at 
30°C on synthetic complete (SC) media for plasmid selection. 
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Table 4S.1. Yeast Saccharomyces cerevisiae strains used in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain Genotype Reference 
BY4741 MATa  his3∆1 leu2∆0 met15∆0 ura3∆0  Open Biosystems 
BY4741 Δcue1 MATa  his3∆1 leu2∆0 met15∆0 ura3∆0 cue1::KanMX Open Biosystems 
BY4741 Δdoa10 MATa  his3∆1 leu2∆0 met15∆0 ura3∆0 doa10::KanMX Open Biosystems 
BY4741 Δhrd1 MATa  his3∆1 leu2∆0 met15∆0 ura3∆0 hrd1::KanMX Open Biosystems 
BY4741Δhrd1 Δdoa10 MATa  his3∆1 leu2∆0 met15∆0 ura3∆0 hrd1::KanMX  doa10::HIS3 This study 
BY4741 Δubc6 MATa  his3∆1 leu2∆0 met15∆0 ura3∆0 ubc6::HIS3 (42) 
BY4741 Δubc7 MATa  his3∆1 leu2∆0 met15∆0 ura3∆0 ubc7::KanMX Open Biosystems 
BY4741 Δubc6 Δubc7 MATa  his3∆1 leu2∆0 met15∆0 ura3∆0 ubc6::HIS3 ubc7::NatMX (42) 
SEC23 MATα ura3-52 leu2-3,-112 (25) 
sec23-1 MATα ura3-52 his4-619 sec23-1 (25) 
CDC48 MATa ura3-52 his3∆200 leu2∆1 trp∆63 (43) 
cdc48-1 MATa ura3-52 his3∆200 leu2∆1 trp∆63 cdc48-3 (43) 
W303-1b MATα  ade2 his3 leu2 ura3 trp1 can1-100  (19) 
KNY111 MATα  ade2 his3 leu2 ura3 trp1 can1-100 DOA10-13MYC-KANMX (19) 
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4.3.3. Selection of yeast mutants constitutively expressing Pca1. A functional 
Pca1 fused with green fluorescent protein (GFP) at the N-terminus was expressed in a 
yeast S. cerevisiae deletion pool (Open Biosystems) containing individual deletions of all 
nonessential genes. Highly fluorescent cells (top 1% among the collected ~400,000 
transformants) were sorted by flow cytometry. Positive candidates were confirmed by 
confocal microscopy and gene knockouts were identified using specific primer sets for 
PCR amplification and sequencing of a unique 20 base “tag” sequence (10). 
4.3.4. Preparation of cell extracts and immunoblotting. All immunoblotting 
was performed essentially as described previously (4). Briefly, total protein extracts were 
prepared by vortexing yeast cells with glass beads in PBS containing protease inhibitor 
cocktail (Complete Mini) (Roche) and 1% triton X-100. Lysates were denatured in SDS 
sample buffer containing 25mM DTT for 15min at 37°C and resolved by SDS-PAGE 
prior to transfer to nitrocellulose membrane and antibody probing. 
4.3.5. Cycloheximide chase analysis. Protein synthesis was inhibited by the 
addition of 100 µg/mL cycloheximide to logarithmically growing cultures. Cells 
(A600=15) were collected into equal volumes of ice-cold kill buffer (PBS containing 15 
mM NaN3) at the indicated time points. For zero time points, cells were collected before 
addition of cycloheximide. Cells were pelleted by centrifugation and stored at -80°C until 
preparation of cell extracts for SDS-PAGE and immunoblotting (6). Pca1 was detected 
by chemiluminescence using anti-HA antibodies and horseradish peroxidase (HRP)-
conjugated anti-rabbit IgG antibodies. Phosphoglycerate kinase (PGK) was probed as a 
loading control using anti-PGK antibodies and HRP-conjugated anti-mouse IgG 
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antibodies. Signals were quantified using Total Lab TL100 software and were normalized 
to PGK. 
 4.3.6. 64Cu blotting and autoradiography. Hemagglutinin (HA) epitope-tagged 
Pca1(250-350) or Pca1(250-350)ΔCys where all cysteine residues were mutated to 
alanine were immunoprecipitated from Δdoa10 cell lysates using anti-HA antibody-
conjugated beads (Pierce). Samples were subjected to SDS-PAGE and electroblotted onto 
a nitrocellulose membrane. Membranes were equilibrated in metal binding buffer (17), 
probed with ~10 μCi of 64Cu (~1µM CuCl2) (Isotrace Technique) for 1hr, and then 
washed extensively prior to autoradiography and protein staining (MemCode) (Pierce). 
Competition with 64Cu binding was determined in the presence of 5-fold excess of non-
radioactive competitor ions. 
 4.3.7. Limited trypsin proteolysis of Pca1(250-350). Cytosolic fractions were 
obtained from Δdoa10 cells expressing triple HA epitope-tagged Pca1(250-350) or 
Pca1(250-350)ΔCys cultured with or without cadmium (50µM CdCl2, 1hr). Lysates were 
incubated with trypsin (Sigma) for 10min on ice before addition of 0.2µg/mL soybean 
trypsin inhibitor (Fluka BioChemika) for an additional 15min on ice. Proteolysis patterns 
were visualized by anti-HA immunoblotting. 
4.3.8. β-Galactosidase reporter assay. Cells were assayed for β-galactosidase 
expression as described previously (18). Briefly, cells (A600=1) were permeabilized with 
chloroform and 0.1% SDS in 1mL of Z buffer and incubated with 0.2 mL of 4 mg/mL 
ONPG (ortho-Nitrophenyl-β-galactoside) dissolved in Z buffer. Reactions were quenched 
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by adding 0.5 mL of Na2CO3. β-Galactosidase levels were converted to Miller units 
[(A420)/(Tmin)(VmL)(A600)]. 
 4.3.9. Microsome preparation and chemical cross-linking. Microsome 
preparation was performed as previously described with modifications (19). Cells 
(A600=30) were disrupted by glass bead vortexing in 300µL lysis buffer (20mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 50mM potassium acetate 
(KoAc), 2mM ethylenediaminetetraacetic acid (EDTA), 0.1M sorbitol, 1mM 
dithiothreitol (DTT), 1mM phenylmethanesulphonylfluoride (PMSF) and HALT protease 
inhibitor cocktail (Pierce) for ten 30sec intervals alternating with incubation on ice. An 
additional 250µL buffer 88 (20mM HEPES, 50mM KOAc, 250mM sorbitol and 5mM 
magnesium acetate (MgOAc) was added. Unbroken cells and glass beads were cleared by 
low speed centrifugation (3,000rpm for 5min) and then repeated with a second rinse with 
buffer 88. The supernatant fractions were pooled and centrifuged 18,000g for 20min at 
4°C. The supernatant was decanted and the final microsomal membrane pellet was 
washed once and re-suspended in 150µL of 0.2M triethanolamine, pH 8.0 and incubated 
on ice for 1hr with 100µg/mL dimethyl 3,3’-dithiobispropionimidate (DTBP) a water 
soluble, membrane permeable and thiol reversible cross-linker. Cross-linking reactions 
were quenched by addition of 40uL of 1M Tris (pH 7.5) and incubated on ice for an 
additional 20min. Cell pellets were collected by centrifugation at 18,000g for 15min at 
4°C and washed with 400µL PBS. For membrane solubilization, cell pellets were 
resuspended in 100µL of 1% SDS in PBS and incubated at 37°C for 30min. Triton X-100 
was added for a total concentration of 1.5% (400µL total volume) and incubated on ice 
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for an additional 30min. From this lysate, HA-tagged proteins were immunoprecipitated 
with anti-HA antibody-conjugated sepharose beads (Pierce) overnight at 4°C according to 
manufacturer.  Immobilized proteins were eluted with 2XSDS sample buffer at 37°C for 
15min. Chemical cross-linking was reversed by incubation with 0.1M DTT for an 
additional 15min at 37°C before SDS-PAGE and immunoblotting. 
 4.3.10. Oligomycin resistance assay. Wild type and Δdoa10 strains expressing 
empty vector, Yor1-GFP or Pca1(1-392)-Yor1-GFP  were cultured in SC selective media 
to mid-log phase. Cells (~5 µL, A600=0.1) were spotted on solid YPEG media (2% Bacto-
Peptone, 1% yeast extract, 2% ethanol, 3% glycerol and 1.5% agar), prepared with or 
without the addition of cadmium (10µM CdCl2) and oligomycin (2.5µg/mL). Plates were 
incubated at 30°C for two days before photography. 
4.3.11. Immunoprecipitation and detection of ubiquitin. Cells were broken by 
glass beads vortexing in PBS containing protease inhibitors (Complete Mini) (Roche), 
5mM N-ethylmaleimide, 1mM PMSF and 1% Triton X-100. HA epitope tagged proteins 
were immunoprecipitated with an HA-Tag IP/Co-IP kit (Pierce) according to 
manufacturer specifications. Proteins were eluted by incubation of immobilized anti-HA 
agarose beads in 2XSDS sample buffer at 37°C for 15min and reduced in the presence of 
0.1M DTT for an additional 15min at 37°C. Ubiquitin conjugated proteins were detected 
by immunoblotting using mouse monoclonal antibodies against ubiquitin (Covance).  
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4.4. Results 
 4.4.1. Pca1 is targeted for ER-associated degradation in the absence of 
cadmium. In order to identify molecular factors involved in Pca1 turnover, we selected 
yeast mutants exhibiting defects in Pca1 degradation. An expression construct of a fully 
functional Pca1 fused with green fluorescent protein (GFP-Pca1) was transformed into a 
collection of mutant yeast strains, each lacking a single nonessential gene (10). Cells 
emitting strong GFP signal (as a consequence of a defect in degradation of the GFP-Pca1 
fusion) were selected using a flow cytometer, and gene deletions resulting in high Pca1 
expression were identified (Fig. 4.S1A).   
 Unexpectedly, Pca1 is highly expressed in cells with deletions of the CUE1 gene 
(Fig. 4.S1B and 4.S1C). CUE1 encodes an ER membrane-bound protein that recruits 
Ubc7, a cytosolic ubiquitin-conjugating enzyme, to the ER surface (20). Given that Cue1 
is a crucial factor involved in ERAD, we further examined Pca1 stabilization in yeast 
strains bearing deletions in factors required for ERAD, including Ubc7 (21) and Ubc6 
ubiquitin-conjugating enzymes (22), and ER resident Doa10 (23) and Hrd1 (24) ubiquitin 
ligases. In yeast, the recognition of integral membrane ERAD substrates is governed by 
the location of the misfolded domain. Lesions in soluble domains on the cytosolic face of 
the ER belong to the ERAD-C (cytoplasmic pathway) in which their ubiquitination and 
degradation are largely dependent on Doa10 (8,9). On the other hand, Hrd1 is involved in 
ubiquitination and degradation of substrates with misfolded regions in soluble luminal 
domains (ERAD-L) or within transmembrane domains (ERAD-M) (8,9). Pca1 
stabilization was evident in Δubc7 or Δdoa10 but not Δhrd1 strains (Fig. 4.1A).  
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Cycloheximide chase of HA-Pca1 further confirmed no significant role for Hrd1 in Pca1 
turnover (Fig. 4.1B), indicating the specificity of Doa10 in Pca1 turnover.  Consistent 
with ubiquitination by this E3 ligase, Pca1 ubiquitination was dramatically reduced in the 
Δdoa10 strain (Fig. 4.1C). Pca1 turnover was also decelerated in Δubc6 strain, but to a 
lesser extent than in the Δubc7 strain (Fig. 4.S2). Collectively, these data indicated that in 
the absence of its cadmium substrate, Pca1 was rapidly degraded through the ERAD 
pathway. Given that we could only select CUE1 null mutants multiple times despite 
several ERAD components are involved in Pca1 turnover, our selection of mutants was 
not saturated.  
4.4.2. Degradation of Pca1 and cadmium sensing occur at the ER. Given that 
Pca1 degradation and ubiquitination required Doa10, an ER-resident ubiquitin ligase, we 
reasoned that Pca1 degradation occurs before its secretion from the ER. To demonstrate  
Figure 4.S1. Genetic Screen conducted to identify factors involved in Pca1 
degradation. A, Schematic of genetic screen strategy. B, Confocal 
fluorescence microscopy of wildtype or Δcue1 cells expressing GFP-fused 
Pca1. C, Western blot of HA-Pca1 expressed in Δcue1 background. PGK was 
probed as a loading control. 
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Figure 4.1. Pca1 is degraded through the ERAD pathway. (A) Confocal 
microscopy of GFP-fused Pca1 expressed in wildtype (WT), Δcue1, Δubc7, 
Δdoa10 or Δhrd1 strains. (B) Cycloheximide chase and immunoblotting of HA 
epitope tagged Pca1 (HA-Pca1) expressed in wildtype (WT), Δhrd1, Δdoa10 or 
Δdoa10 Δhrd1 strains at the indicated time points. Each blot was probed for 
phosphoglycerate kinase (PGK) to determine equal loading. For quantification, 
pixel densities of HA-Pca1 were normalized to those of PGK. Average ±S.D. of 
three independent experiments is graphed (lower panel). (C) Detection of 
ubiquitin-conjugated Pca1. Immunoprecipitation of HA-Pca1 in wildtype (WT) or 
Δdoa10 cells followed by Western blot with anti-Ub or HA antibodies. Arrow 
indicates expected migration of HA-Pca1.  
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this hypothesis, we first examined the fate of Pca1 turnover in a sec23-1 mutant which 
exhibits a temperature sensitive defect in COPII vesicle dependent ER to Golgi 
trafficking (25). As shown in Fig. 4.2A, trapping Pca1 in the ER had no significant effect 
on turnover rate, demonstrating that Pca1 degradation does not require its exit from the 
ER. Second, we determined the stability of Pca1 in a temperature sensitive mutant of the 
Cdc48/Np14p/Ufd1 AAA-ATPase, which is required for efficient ER extraction and 
degradation of integral membrane ERAD-C substrates such as Ste6*, a mutant plasma 
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Figure 4.S2.  Roles for Ubc7 and Ubc6 ubiquitin conjugating enzymes in Pca1 
turnover. (A) Cycloheximide chase and immunoblotting of HA epitope tagged 
Pca1 expressed in wildtype (WT), Δubc6, Δubc7, or Δ ubc6 Δubc7 strains at the 
indicated time points. Each blot was probed for phosphoglycerate kinase (PGK) to 
determine equal loading. Representative data from three independent experiments 
is shown. (B) For quantification, pixel densities of Pca1 were normalized to those 
of PGK. 
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membrane protein (26). Consistent with a role for Cdc48 in Pca1 turnover, stabilization 
of Pca1 is apparent in the cdc48-3 strain compared to its isogenic wild-type strain at 
restrictive temperature (Fig. 4.2B). Since Pca1 degradation occurs at the ER, it would be 
intuitive that cadmium sensing which blocks degradation would also occur at the ER. As 
expected, addition of cadmium to cell cultures prevented Pca1 degradation when ER exit 
is blocked (Fig. 4.2C). 
 
 
 
 
 
 
 
Figure 4.2. Pca1 degradation and cadmium sensing occur at the ER. (A) HA-
ragged Pca1 was expressed in SEC23 and a sec23-1 temperature sensitive mutant. 
To block ER to Golgi transport, cells were cultured at restrictive temperature 
(37°C for 30min). After cycloheximide addition to culture media, cells were 
collected at the indicated time points. Pca1 was detected by Western blotting using 
anti-HA antibodies. (B) Cycloheximide chase and Western blotting of HA-Pca1 
expressed in CDC48 and a cdc48-3 temperature sensitive mutant cultured at 
restrictive temperature (37°C for 30min). (C) Cadmium enhances Pca1 expression 
when ER to Golgi transport is blocked. A sec23-1 strain expressing HA-Pca1 was 
cultured at restrictive temperature (37°C for 30min) prior to the addition of 
cadmium (50µM CdCl2) for an additional 30min at restrictive temperature before 
collection for immunoblotting. Each blot was probed for PGK to determine equal 
loading. 
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  4.4.3. Inhibition of Pca1 ERAD by cadmium is specific. To confirm if the 
inhibitory effect of cadmium on ERAD is specific to Pca1, we addressed possible toxic 
effects of cadmium on ER functions, such as inhibition of ERAD machinery, or 
saturation of ERAD capacity by excess accumulation of damaged and/or misfolded 
proteins. Accumulation of misfolded proteins in the ER generally leads to induction of 
the unfolded protein response (UPR) (27). The overall status of ER function was 
monitored with a UPR reporter construct (UPRE-LacZ) (13). Despite being an ERAD 
substrate, constitutive expression of Pca1 did not lead to any significant increase in 
reporter gene expression over basal levels (Fig. 4.3A). Cadmium concentrations that 
induce robust expression of Pca1 (Fig. 4.3B) led to a minimal UPR response (Fig. 4.3A), 
whereas DTT strongly enhanced reporter levels (Fig. 4.3A) without affecting Pca1 
expression (Fig. 4.3B).  Furthermore, cadmium did not stabilize Ste6*, a well-studied 
Doa10 substrate (Fig. 4.3C). Collectively, these data indicated that the cadmium 
dependent stabilization of Pca1 is specific and was not due to over-accumulation of 
misfolded protein intermediates or the inactivation of ERAD machinery. 
  4.4.4. The N-terminus of Pca1 contains a targeting signal for ERAD. Aberrant 
secretory proteins typically engage quality control checkpoints, which prevents their exit 
from the ER. For instance, when the ERAD pathway is inactivated, some substrates are 
trapped in the ER rather than being secreted to the plasma membrane (26,28). We took 
advantage of the ability of the Yor1 ATP-binding cassette (ABC) transporter to extrude 
oligomycin, a mitochondrial toxin (29). If the Pca1 degron prevents ER exit, then Yor1 
fused with this degron would be retained in the ER and no oligomycin resistance would  
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be conferred. Fusion of Pca1(1-392) converted the normally stable Yor1 transporter to an 
unstable substrate which is stabilized by cadmium in culture media or deletion of DOA10 
(Fig. 4.S3). Consistent with its rapid proteolysis, in the absence of cadmium the Pca1(1-
392)-Yor1-GFP fusion did not confer resistance to oligomycin (Fig. 4.4A, third row, 
middle panel). However, upon supplementation of cadmium (Fig. 4.4A, third row, right 
panel) or expression in a Δdoa10 strain, (Fig. 4.4A, fourth row, middle panel) the fusion 
protein confers oligomycin resistance. These results demonstrate that the Pca1(1-392)-
Yor1-GFP fusion reaches the cell surface for oligomycin efflux when its degradation is  
Figure 4.3. Cadmium-dependent inhibition of Pca1 ERAD is specific. (A) 
Unfolded protein response (UPR) determined by a UPRE-LacZ reporter construct 
(13). Empty vector (-) or an expression construct of HA epitope tagged Pca1 (+) 
was co-transformed with a UPRE-LacZ reporter construct in a wild-type (WT) 
yeast strain. Cells were cultured in SC selective media with (+) or without (-) 
supplementation of cadmium (Cd) (50µM CdCl2, 1hr). As a positive control of 
UPR response, cells were cultured with DTT (2mM, 1hr) (13). Each bar represents 
the average ± S.D. of β-galactosidase activities of four different samples. (B) 
Western blot analysis of HA-Pca1 expressed in non-treated cells (NT) or cells 
cultured in media supplemented with cadmium (Cd) (50µM CdCl2) or DTT 
(2mM) for 1hr. (C) Western blot analysis of HA epitope tagged Ste6* in WT or 
Δdoa10 cells cultured without (-) or with (+) supplementation of cadmium (Cd) 
(50µM CdCl2, 1hr) to culture media. Each blot was PGK to determine equal 
loading. 
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prevented. Oligomycin resistance in the Δdoa10 strain expressing the Pca1(1-392)-Yor1-
GFP fusion without cadmium suggests that metal sensing is not a prerequisite for ER 
exit. This is also in agreement with our previous observation where deletion of residues 
1-392 did not perturb Pca1 trafficking or function (6).  
 We next examined whether the Pca1 degron can target a cytosolic protein for 
ERAD. Our previous mapping of the Pca1 N-terminus identified a minimal region 
encompassing amino acids 250-350 to be sufficient for rapid degradation (6). Expression 
of a soluble GFP reporter C-terminally fused to Pca1 residues 250-350 (GFP-Pca1(250-
350)) was regulated in a cadmium and Doa10 dependent manner (Fig. 4.4B). However, 
cadmium did not prevent turnover of GFP fused with CL1, an artificial Doa10 degron 
(30) (Fig. 4.4B). These data indicate that the Pca1 degron can also target a cytosolic 
protein for ERAD. We conclude that the Pca1 degron does not function as either an ER 
Figure S4.3. Cadmium and Doa10 dependent regulation of Pca1(1-392)-Yor1-
GFP 
Confocal fluorescent microscopy of Yor1-GFP and Pca1(1-392)-Yor1-GFP 
expressed in a WT and Δdoa10 cells non-treated (NT) or with addition of 
cadmium (50µM CdCl2, 1hr) . 
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exit or retention signal but rather serves as a targeting signal for Doa10 dependent 
ERAD.  
 
 
 
 
 
 
 
4.4.5. Physical interaction between Pca1 and Doa10 via the N-terminal 
degron. We hypothesized that the N-terminus of Pca1 functions as a Doa10 recognition 
motif.  Pca1 and Doa10 interaction was determined by chemical crosslinking. 
Microsomes were prepared from cells expressing thirteen c-myc epitope-tagged Doa10 
(Doa10-myc) (19) and a fully functional HA-tagged Pca1 (HA-Pca1), or with deletion of 
Figure. 4.4. A degron in the N-terminus of Pca1 is not an ER retention 
signal. A, Cell growth on media containing oligomycin. Cells (5µl of cells diluted to 
A600= 0.1) were spotted on YPEG solid media that was made with (+) or without (-) 
the addition of oligomycin (2.5µg/mL) and/or cadmium (10µM CdCl2). Cell growth 
was monitored after 3 days. B, GFP without or with fusion of Pca1(250-350) or the 
CL1 artificial degron were expressed in WT and Δdoa10 strains. Cells were cultured 
in media with (+) or without (-) supplementation of cadmium (50µM CdCl2, 1hr). GFP 
levels in total protein extracts were measured by Western blotting using anti-GFP 
antibodies. Each blot was probed for phosphoglycerate kinase (PGK) to determine 
equal loading. 
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the N-terminal regulatory domain (HA-Pca1Δ392) (6). Ste6* served as a positive control 
for physical interaction between an ERAD substrate and Doa10 (19). Microsomes were 
treated with dimethyl dithiobispropionimidate (DTBP), a thiol reversible and membrane 
permeable cross-linker, and HA-tagged proteins were immunoprecipitated by anti-HA 
conjugated sepharose beads. Doa10 was co-precipitated from cells expressing Pca1 or 
Ste6* but not Pca1Δ392 which lacks the N-terminal degron (Fig. 4.5 first panel). This 
data demonstrated that the N-terminus is required for either direct or indirect interaction 
of Pca1 with Doa10. 
4.4.6. Metal binding and conformational change of the Pca1 degron. Given 
that cadmium or copper rescued Pca1 from degradation and that the Pca1 N-terminus 
contains potential metal binding residues (6), we predicted that metal binding to this 
region would mask a degradation signal. Since attempts to purify adequate amounts of 
this protein have been a technical challenge, we utilized a (64Cu(II)) blotting assay (17) in 
which HA-Pca1(250-350)  was immunoprecipitated using anti-HA antibody conjugated 
beads and transferred to a nitrocellulose membrane. Autoradiography of blots incubated 
with 64Cu showed specific binding of radioactive copper to HA-Pca1(250-350) as no 
signal was observed from bands corresponding to the same peptide in which all seven 
cysteine residues were mutated to alanine (HA-Pca1(250-350)ΔCys) (Fig. 4.6A). Cu(II) 
or Cd(II) but not Zn(II) effectively competed for 64Cu(II) binding implying that copper 
and cadmium can compete for the same binding site(s)  (Fig. 4.6B). Cd(II) appeared to 
compete more effectively than copper at the same concentration (Fig. 4.6B), suggesting 
higher  
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binding affinity. These metal binding specificities were in accordance with previously 
observed cadmium and copper specific regulation of Pca1 stability (4).  
 To examine conformational changes associated with metal binding, we employed 
a limited trypsin proteolysis assay of the Pca1 degron (HA-Pca1-(250-350)). Western 
Figure 4.5. The N-terminal regulatory domain is required for physical interaction 
between Pca1 and Doa10. Expression constructs of HA-Pca1, Pca1 deleted of amino 
acid residues 1-392 (HA-Pca1Δ392), or Ste6* (HA-Ste6*) were expressed in a strain 
containing a chromosomal integration of 13 c-myc epitope tagged Doa10 (Doa10-
myc). Chemical cross-linking was performed using microsomes prepared from these 
cells (See Materials and Methods). HA tagged proteins were immunoprecipitated (IP) 
and denatured under reducing conditions to break crosslinking. Samples were 
subjected to SDS-PAGE and Western blotting (W) using anti-myc antibodies (IP:HA, 
W:myc), and then the same blot was stripped and re-probed with anti-HA antibodies 
(IP:HA, W:HA). Total protein extracts were resolved on SDS-PAGE and analyzed by 
Western blotting using anti-HA (W:HA) or anti-myc (W:myc) antibodies. 
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4.5. Discussion 
 Our data supports a model (Fig. 4.7) illustrating an unanticipated regulatory 
mechanism by which cells control the expression of a plasma membrane protein. In the 
absence of cadmium, newly synthesized Pca1 is targeted for ERAD by an N-terminal 
degron resulting in rapid turnover at the proteasome. Cadmium sensing by this degron 
induces a conformational change, which prevents the recognition of Pca1 by the ERAD 
machinery. Hence, cells are able to rapidly elevate Pca1 expression in response to 
cadmium.  
 Given that cadmium is an extremely toxic metal of which environmental levels 
fluctuate, the constant synthesis of a cadmium exporter would be advantageous for cell 
survival. ERAD of Pca1 at the early step of synthesis keeps Pca1 levels at a minimum, 
since expression is not necessary when cells are growing without cadmium stress. It is 
also possible that Pca1 could play a role other than cadmium efflux, which would be 
deleterious in the absence of cadmium. For instance, if Pca1 transports nutritional metal 
ions due to low substrate specificity as shown for other P1B-type ATPases (31), the 
constant degradation of Pca1 would prevent the loss of essential metals that are limiting 
for growth.  
 ERAD eliminates misfolded or unassembled proteins, which is necessary for the 
prevention of toxic accumulation of aberrant proteins (8, 9). At least 30% of newly 
synthesized proteins are rapidly degraded by proteasomes (32). It has been suggested that 
this observation represents the degradation of misfolded proteins and defective ribosomal 
products resulting from errors in translation. This pool of peptides also provides both host 
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and viral antigenic peptides to be displayed by MHC class I molecules (33). Our study 
presented herein suggests another unexplored role for ERAD, which occurs in a degron-
dependent manner and would allow for fine tuning of secretory protein expression in 
response to cellular cues.  
 Regulation of Pca1 expression at the ER may represent a conserved and largely 
uncharacterized system by which cells control the expression levels of secretory proteins. 
Consistent with this argument, molecular factors in the ERAD pathway are involved in 
regulated destruction of proteins. Sterol metabolic status regulates ERAD of ER-resident 
HMG-CoA reductase, the rate-limiting enzyme of sterol synthesis (34). Co-translational 
degradation of apolipoprotein B at the ER is enhanced when lipid efflux from the liver is 
not favored (35). In yeast, the Doa10 ubiquitin ligase also targets the cytoplasmic 
MATα2 repressor for degradation in the absence of its MATa1 binding partner (36). 
However, Pca1 is the first plasma membrane protein that is targeted to the ERAD 
pathway by a degron in a substrate-dependent manner. 
 There is accumulating evidence suggesting expressional control of plasma 
membrane transporters and ion channels early in the secretory pathway, although the 
implication of ERAD in this process has not been firmly established. For instance, it was 
shown that ubiquitination and proteasome-dependent degradation affects the expression 
of a variety of cell surface proteins such as aquaporin (37), acetylcholine receptor (38), 
ATP sensitive K+ channels (39), and opioid receptors (40). Intriguingly, under normal 
conditions only 40% of newly synthesized human δ opioid receptors ever reach the cell 
surface; however membrane-permeable opioid ligands facilitate maturation and ER 
132 
export (41). It is of interest to determine whether this opioid dependent degradation of its 
receptor occurs by a similar mechanism that we have established for Pca1. 
 It is unknown whether Doa10 directly recognizes the Pca1 degron or whether 
other accessory factor(s) recruit Pca1 for ubiquitination. The requirement of the Pca1 N-
terminus in the co-precipitation of Doa10 suggests a physical interaction between the 
Pca1 degron and Doa10, although it is not certain yet whether this interaction is mediated 
by other factor(s). In the case of Ste6*, cytosolic Hsp70 chaperones aid in this process 
(19). However, our preliminary data did not indicate any significant role for Hsp70 
chaperones in Pca1 ERAD. 
 The recognition determinants of the Pca1 degron and that of other ERAD 
substrates remain unknown. The current hypothesis is that misfolded proteins display 
normally buried hydrophobic residues to the cytosolic surface, which serves as a 
targeting signal for degradation. The Deg1 degron of MATα2 repressor is predicted to 
form an amphipathic helix of which hydrophobic residues are crucial for its instability 
(36). However, there is no obvious similarity in the primary sequence of Deg1 and the 
Pca1 degron. Our preliminary mutagenesis studies have revealed that single amino acid 
substitutions of hydrophobic residues hinder ERAD recognition of the Pca1 degron. 
These observations suggest that specific characteristics within this degron are recognized 
by the ERAD machinery rather than a general misfolded structure as has been postulated 
for other ERAD substrates. Structural characterization of the Pca1 metal sensing degron 
in apo and metal-bound forms would define what features attract the ERAD machinery. 
This study would also provide useful information for the identification of other proteins 
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that may possess a similar type of degradation signal. While the Pca1 degron does not 
have significant sequence identity with known proteins, we could identify potential metal 
binding cysteine and histidine-rich extensions in predicted Pca1 family members of 
plants (31) and fungi. We are currently testing whether expression of these proteins or if 
other proteins in yeast, plants and mammals are also regulated by ERAD. 
 The identification of the molecular factors involved in Pca1 turnover reveals a 
novel regulatory mechanism by which yeast cells selectively control the expression of a 
plasma membrane protein at an early step of synthesis. Small molecules, including 
substrates or metabolites, or signaling pathways may actively regulate protein secretion at 
the ER in a target specific manner as demonstrated for Pca1.  
 
 
 
 
 
 
Figure 4. 7 Model of cadmium-regulated expression of Pca1. Cadmium sensing 
occurs at the ER by metal binding to the cytosolic N-terminal domain of Pca1 
followed by conformational changes which prevents recognition for ubiquitination by 
ERAD factors, including Cue1, Ubc7, and Doa10. Pca1 extraction from the ER is 
facilitated by Cdc48 after ubiquitination. Black squares indicate Pca1 trans-membrane 
domains. Black arrow indicates cadmium efflux via Pca1 at the plasma membrane. 
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Chapter 5 
Significance and Future Directions 
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5.1. Identification of a New Metal-transporting P-type ATPase 
 Cadmium is a serious environmental contaminant implicated in various disorders. 
Human exposure to cadmium is unavoidable and widespread.  In the context of these 
public health concerns, understanding the mechanisms of heavy metal metabolism 
represents an important research avenue. Pca1 represents the first cadmium-specific 
efflux system. Knowledge gained from this study may lead to the development of new 
strategies for prevention and treatment of cadmium related disorders.  
 P1B-type ATPases are divided into different subclasses based on structural 
features and substrate specificity. Sequence alignments which have identified conserved 
metal binding residues have been used to predict substrate specificity, although the 
structural determinants of substrate specificity for P1B-type ATPases have not been firmly 
established. According to these criteria, Pca1 is currently classified as a copper (I) 
translocating P1B-type ATPase; however, functional characterization of Pca1 supports 
cadmium selectivity. Given that all known cadmium translocating P1B-type ATPases in 
plants and bacteria also transport other divalent heavy metals (e.g. zinc (II), lead (II), 
cobalt (II), mercury (II) ), Pca1 appears to be a new P1B-type ATPase subtype. Since, a 
mechanistic understanding of the determinants of substrate specificity are lacking, Pca1 
will be an important tool for understanding ion selectivity of P1B-type ATPases.  
Our BLAST searches have revealed several potential Pca1 homologues from 
fungi that have high sequence identity and similarity with Pca1 (Figure 5.1). Cloning and 
functional characterization of these genes would establish a new cadmium-specific 
subtype of a P1B-type ATPase 
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It does not appear that a cadmium-transporting P1B-type ATPase exists in the 
human genome in addition to copper-transporting ATP7a and ATP7b. However, several 
lines of evidence suggest that mammals possess cadmium export mechanism(s). 
Identification of cadmium exporters in humans would lead to better understanding of the 
mechanisms of cadmium detoxification and open up a new research avenue for 
combating cadmium-related disorders.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Organism % identity % similarity
G .zea 45.0 62.5
P .janthinellum 45.6 60.9
A. fumigatus 43.0 59.8
A.clavatus 42.4 58.5
C. immitus 33.7 51.8
B.fuckeliana 33.5 46.9
Figure 5.1.  Sequence comparisons and phylogenetic tree of possible functional 
homologues of Pca1 from other fungi. Protein sequences were retrieved from the NCBI 
data base. Alignments  were produced by Clustal W. 
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5.2. Genetic Variations in Molecular Factors Involved in Cadmium Detoxification 
Sequence comparisons of Pca1 revealed a missense mutation in a critical residue, 
which leads to a non-functional Pca1 allele. This mutation exists in several laboratory 
strains but not in natural isolates. The most plausible explanation is that the ancestral 
strain harboring the G970R mutation was propagated to research laboratories across the 
world. The non-functional Pca1 allele at least in part explains the cadmium 
hypersensitivity of laboratory yeast strains compared to natural strains. It is interesting to 
note that a natural strain deleted of Pca1 was still more resistant to cadmium than a 
laboratory yeast strain (unpublished data), which suggests that other cadmium resistance 
factors remain to be discovered. Metal concentrations in the environment are variable and 
can rapidly fluctuate, imposing a strong selection pressure for cadmium defense genes. 
Population bottlenecks and decreased selection pressure in a laboratory environment have 
likely resulted in the accumulation of deleterious mutations in genes involved in 
cadmium resistance. The genetic variation of cadmium resistance among yeast strains 
provides an interesting research model to identify new cadmium resistance genes and 
explore gene-environment interactions associated with evolution.  
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5.3. A Novel Mode of Expressional Control of a Plasma Membrane Protein  
For the first time, our work has definitively demonstrated that the expression 
levels of a plasma membrane protein can be regulated at the ER in response to cellular 
needs. Importantly, we have also isolated a specific response element and have offered a 
mechanistic explanation for ligand dependent masking of an ERAD signal. Several layers 
of evidence have been presented which support these claims. First, Pca1 is rapidly 
degraded via the ubiquitination-proteasome pathway; however in the presence of its 
cadmium substrate, ubiquitination is inhibited, resulting in Pca1 stabilization. Second, 
Pca1 degradation requires components of the ERAD pathway, including ER resident E2 
and E3 ubiquitin ligases. Third, cysteine dependent metal binding to the Pca1(250-350) 
domain result in conformational changes, which is believed to be a mechanism of 
degradation signal masking. 
It is of interest to determine whether any other cell surface proteins are regulated 
at the ER in a similar manner as has been demonstrated for Pca1. Indeed, the ubiquitin 
proteasome system has been implicated in modulation of a variety of cell surface proteins 
including, aquaporin (1), ACh receptor (2), ATP sensitive K+ channels (3), and opioid 
receptors (4). Intriguingly, under normal conditions only 40% of newly synthesized 
human δ opioid receptors ever reach the cell surface. However, membrane-permeable 
opioid ligands can facilitate their maturation and ER export (5). Ligand and/or cellular 
signal-dependent escape of ERAD by secretory proteins may be a prevalent but 
uncharacterized regulatory mechanism determining protein expression levels in response 
to cellular needs.   
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5.4. A New Protein Degradation Signal 
A fundamental question that remains unanswered is whether the mode of Pca1 
regulation and its degradation signal are conserved in other P1B-type ATPases or other 
unrelated proteins. Sequence alignments of the degradation signal motif in Pca1 with 
close homologues in fungi have revealed a consensus sequence (Figure 5.2). 
Interestingly, cysteine residues implicated in copper or cadmium binding are completely 
conserved. Selective mutagenesis of other conserved residues and cloning and 
characterization of these Pca1 homologues will determine if cadmium-regulated ERAD is 
conserved among these proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. Determinants of the Pca1 Degron. (A) Sequence alignment of the 
Pca1(250-350) domain with putative Pca1 homologues. Cysteine residues previously 
implicated in metal binding are highlighted. Arrow indicates P314 and F318. (B) 
Confocal fluorescent microscopy of GFP-Pca1 or mutant alleles expressed in a wild-type 
yeast strain.  
144 
5.5. Does the ERAD Machinery Recognize a Specific Signal Rather Than General 
Misfolding? 
The structural features of ERAD substrates and how they are recognized for 
delivery to the ER degradation machinery remain unknown. The current hypothesis is 
that degrons display characteristics of misfolded proteins in which normally buried 
hydrophobic residues are exposed to the cytosolic surface. Due to a lack of structural 
data, the only insight into the degradation requirements of a natural degron come from 
mutational analysis of the Deg1 signal identified from yeast MATα repressor. A similar 
approach will identify key determinants for recognition of the Pca1 degron. Our 
preliminary mutagenesis studies have identified key bulky hydrophobic residues (P314 
and F318) that are major determinants of the Pca1 degron (Figure 5.2). Although these 
residues do not appear to be conserved, they are in close proximity to the C311 and C312 
residues which were previously implicated in cadmium binding (Chapter 3). Ultimately, 
structural characterization of the Pca1 metal sensing degron in apo and metal-bound 
forms would, for the first time, define what features constitute an ERAD signal and how 
they can be masked by ligand binding. 
It is unknown whether the Doa10 E3 ligase directly recognizes the Pca1 degron or 
whether other accessory factor(s) recruit Pca1 for ubiquitination. There is some evidence 
that cytosolic Hsp70 chaperones aid in this process, as is the case for Ste6* (6). However, 
our preliminary data do not indicate any significant role for Hsp70 chaperones in Pca1 
ERAD (unpublished observations). The requirement for the Pca1 N-terminus in the co-
immunoprecipitation of Doa10 suggests an interaction between the Pca1 degron and 
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Doa10.  However, it is not certain yet whether this interaction is mediated by other 
factor(s). Pull down of interacting proteins followed by tandem MS/MS peptide 
sequencing would be a strategy for identification of these factors.  
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5.6. Broad Impact of this Study in Biology and Medicine 
  The unanticipated discovery of Pca1 regulation by ERAD has significant 
implications in understanding cellular regulatory mechanisms of protein expression. For 
some time it has been known that a large fraction of newly synthesized proteins is rapidly 
degraded by proteasomes (7). The current view is that this observation most likely 
represents the degradation of misfolded proteins and defective ribosomal products that 
result from errors in translation. It is becoming increasingly evident, especially after the 
elucidation of Pca1 regulation at the ER, that the degradation of such a large pool of 
newly synthesized proteins may be part of a regulatory process. This mode of regulation 
allows cells to rapidly respond to cellular cues. Ligand binding and/or post-translational 
regulation (e.g., phosphorylation, protein-protein interactions) followed by 
conformational masking of ERAD signals may be a common but largely uncharacterized 
cellular phenomenon. Perhaps a large portion of the secretory proteome is regulated in 
this manner. Characterization of conserved features in degrons like those found in the N-
terminal domain of Pca1 could lead to the identification of other proteins in which ERAD 
plays a regulatory role in protein expression.  Structural characterization of these degrons 
may make it one day possible to design small molecules to control the expression or 
degradation of a select protein through the ERAD pathway as a therapeutic strategy.  
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